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1. Summary 
 
 
In all living organisms, amino acids (AA) are essential building blocks, metabolites and signaling 
molecules. To reach their site of action AA need to pass through polar epithelial cells. Because AA 
cannot freely diffuse through the cell membrane, specific AA carriers ensure their transport across the 
apical and the basolateral membrane. Despite numerous flux studies and huge progress in the 
identification and characterization of these carrier proteins, AA transport across the basolateral 
membrane is not fully understood. The best characterized basolateral transporters in the small intestine 
and kidney proximal tubule are the obligatory exchanger (antiporter) Lat2-4F2hc (Slc7a8) and y
+
Lat1-
4F2hc (Slc7a7). Both require the presence of a "one-way transport" (uniporter) to achieve a net AA 
efflux. TAT1 (Slc16a10) and LAT4 (Slc43a2) fulfill this requirement with different substrate 
selectivities: TAT1 facilitates the diffusion of aromatic AA, whereas Lat4 transports branched chain 
AA, some aromatic AA, Met and Pro. The functional cooperation between TAT1 and Lat2-4F2hc has 
previously been shown using the X. laevis oocyte expression system (Ramadan, Camargo et al. 2007). 
An analogous functional cooperation was also shown for Lat4. Indeed, TAT1 shows the same 
localization as LAT2-4F2hc in epithelial cells and is further present in muscle sarcolemma and 
perivenous hepatocytes. The precise localization of Lat4 is still unknown and appears to overlap 
partially with that of TAT1. 
 
The question addressed in this dissertation is: what is the function of TAT1 and Lat4 in vivo? Using 
global knock out mouse models we have examined the effect of the absence of the two uniporters on 
the AA homeostasis and epithelial transport. 
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By inducing specific aminoaciduria in TAT1 defective mice (tat1
-/-
) under high protein diet, we could 
confirm the functional collaboration between TAT1 and LAT2-4F2hc in vivo. Furthermore, tat1
-/-
 
showed elevated aromatic AA in plasma, skeletal muscles and kidney, but not in liver. Thus, we could 
conclude that the absence of TAT1 prevents the maintenance of AA balance between plasma and liver 
and the consequent regulation of AA homeostasis. By means of everted gut sacs and microSPECT/CT 
imaging, we could show that the impairement of AA epithelial transport was caused by an intracellular 
accumulation of the AA substrates. The mild phenotype of tat1
-/-
 strongly suggests a compensatory 
role by Lat4, which is also functionally redundant in the oocyte. In fact, Lat4 defective mice (lat4
-/-
) 
prematurely died within the first five days of life. After birth, the normal size, skin color and behavior 
of lat4
-/-
 pups excluded possible prenatal impairments. Normal suckling behavior further excluded 
possible severe neurological disability. The reduced growth recorded between 24 and 48 hours 
indicated a disorder in food intake or absorption. Further investigations should aim to decipher the 
cause of death. 
 
In conclusion, this study analyzes the function of two basolateral uniporters for the first time in vivo. 
We show that the basolateral transport machinery is still functional in the absence of TAT1, whereas it 
appears to be more impaired in the absence of Lat4. Furthermore, we have shown a new important role 
of TAT1 in the regulation of the aromatic AA concentrations by the coupling of liver cells and blood 
plasma. Further research should aim to better characterize the in vivo interplay between AA 
transporters by the study of combinatorial knock out mice. Finally, the results of the different protein 
rich diets and their influence on the urinary pattern open new questions about the regulation of AA 
transporters in vivo. 
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2. Zusammenfassung 
 
 
In allen Lebewesen sind Aminosäure (AS) essentielle Bausteine, Metaboliten und Signal-Moleküle. 
Um ihren Aktionsort zu erreichen, müssen sie die polaren Epithelzellen passieren. Weil AS nicht frei 
durch die Zellmembran diffundieren können, stellen AS-Transporter an apikalen und basolateralen 
Membranen den spezifischen Transport sicher. Trotz zahlreicher Transport-Studien und grosser 
Fortschritte in der Identifizierung und Charakterisierung der beteiligten Proteine, ist der Transport 
durch die basolaterale Membran nicht vollständig aufgeklärt. Die am besten charakterisierten 
basolateralen Transporter im Dünndarm und proximalen Nierentubulus sind die obligatorischen 
Austauscher (Antiporter) Lat2-4F2hc (Slc7a8) und y+Lat1-4F2hc (Slc7a7). Beide benötigen für ihre 
Funktion einen „Ein-Weg-Transporter“ (Uniporter), um einen Netto-Export der AS zu ermöglichen. 
TAT1 (Slc16a10) und Lat4 (Slc43a2) erfüllen diese Anforderung, aber mit unterschiedlichen 
Substraten. TAT1 transportiert aromatische AS und Lat4 die verzweigtkettigen AS, die aromatischen 
AS, Met und Pro. Im X. laevis Oocyten System wurde die Zusammenarbeit von TAT1 und Lat2-4F2hc 
funktionell gezeigt (Ramadan, Camargo et al. 2007). Lat4 konnte im Oocyten eine äquivalente 
Funktion zu der von TAT1 übernehmen. TAT1 teilt die Lokalisierung mit Lat2-4F2hc in Epithelzellen 
und ist ebenfalls in Muskel und Leber exprimiert. Die genaue Lokalisierung von Lat4 ist unbekannt. 
Die Expression der beiden Uniporter überlappt scheinbar nur teilweise.  
 
Was ist die Funktion von TAT1 und Lat4 in vivo? Mittels globaler knock-out Maus-Modelle haben 
wir die Auswirkung deren Abwesenheit auf die AS-Homöostase und den Epithel-Transport untersucht. 
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Unter hoher Eiweiss-Ernährung bestätigte die Auslösung einer spezifischen Aminoazidurie in TAT1 
knock-out Mäusen (tat1
-/-
) die funktionale Zusammenarbeit zwischen TAT1 und Lat2-4F2hc in vivo. 
Weiter, zeigten tat1
-/-
 Mäuse erhöhte aromatische AS im Plasma, Muskel und in den Nieren, im 
Gegensatz zur Leber. Somit, verhindert die Abwesenheit von TAT1 in Leberzellen den AS-Ausgleich 
mit dem Blut und nachfolgend die AS-Homöostase-Regulation. Mittels „Everted Gut Sac“ und 
„microSPECT“ Experimenten konnten wir zeigen, dass die Beeinträchtigung der epithelialen 
Funktionalität durch eine intrazelluläre Akkumulation der AS-Substrate verursacht wurde. Der milde 
Phänotyp deuted darauf hin, dass Lat4, der funktionell in Oocyte redundant ist, eine zentrale 
kompensatorische Rolle spielt. In der Tat sterben Lat4 Knock-out Mäuse (lat4
-/-
) innerhalb der ersten 
fünf Lebenstage. Die Grösse, die Hautfarbe und das Verhalten der lat4
-/-
 Tiere nach der Geburt liegen 
im normalen Bereich, welches pränatale Gründen ausschliesst. Neurologische Ursachen wurden 
wegen normalem Saugverhalten ausgeschlossen. Der reduzierte Wachstum zwischen 24 und 48 
Stunden deutet auf eine Störung der Nahrungsaufnahme oder -absorption hin. Weitere 
Untersuchungen sollen die Todesursache entschlüsseln.  
 
Im meiner Dissertation haben wir erstmals in vivo zwei bekannte basolaterale Uniporter analysiert. Die 
basolaterale AS Transportmachinerie ist in der Abwesenheit von TAT1 funktionsfähig, während sie 
ohne Lat4 scheinbar versagt. Ausserdem, haben wir eine wichtige neue Rolle von TAT1 in den 
Leberzellen für die Regulation der aromatischen AS-Konzentrationen gezeigt. Weitere Forschung soll 
darauf aufbauen, das in vivo Wechselspiel zwischen AS-Transportern mittels Doppel-Knock-out 
Mäusen weiter zu charakterisieren. Schließlich, haben die Resultate der verschiedenen eiweißreichen 
Diäten und deren Einfluss auf das Urin-Profil neue Fragen über die Regulierung von AS-Transportern 
in vivo eröffnet.  
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3. Introduction 
 
3.1. Amino acids 
 
3.1.1 Amino acids: structure and variety 
Amino acids (AAs) are defined as organic substances which contain an amino group and an acidic 
carboxyl group (Wu 2009) (Fig. 1). AAs can join together with the help of the previously mentioned 
groups forming a peptide bond, and giving rise to a linear polymer of AAs, called polypeptide or 
protein (Fig. 2). Except for glycine, all AAs have both L- and D-isoforms due to their chirality with 
reference to glyceraldehydes, however only the L- isoforms are used for protein formation. Indeed, 
most of the D-AAs can be converted into L-AAs catalized by several oxydases and transaminases, 
which are species specific (Baker 2009; Fang, Luo et al. 2009). Variations in the AA side chain 
(Fig. 1, R-group) distinguish the AA among each other and confer different biochemical properties: 
nonpolar, polar uncharged, polar charged acidic and polar charged basic (Fig. 3). According to the 
chemical conformation of the side chain AAs can also be classified as aromatic AA, which are AAs 
with an aromatic ring and includes phenylalanine, tryptophan, tyrosine and histidine. Another group is 
the one of branched chain AA (BCAA), which includes leucine, isoleucine and valine. The side chain 
also confers its chemical property to the peptides or the part of the protein, which might consequently 
be more hydrophilic or hydrophobic, and the exact AA sequence is crucial for the proper formation of 
secondary and tertiary protein structures. Among more than 300 AA found in nature, only 20 serve as 
building blocks of proteins during mRNA translation (Wu 2009). In addition, four other AAs are 
found in mature proteins as consequence of posttranslational modifications: γ-carboxyglutamic acid, 
hydroxylysine, 4-hydroxyproline and 3-hydroxyproline (Galli 2007). Accordingly to the international 
IUPAC nomenclature AAs are classified with a trivial name (e.g. alanine), a symbol code (e.g. Ala or 
A) and systematic name (e.g. 2-Aminopropanoic acid) (Recommendations 1976). For convenience, in 
this work we refer to the 3-letter code or to the trivial name, always implying the L-isoform (Fig. 3). 
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Fig. 1: Chemical structure of an amino acid. Amino acids (AAs) are organic molecules containing 
an amino and a carboxyl group. The variable side chain (R-group) confers the chemical properties and 
distinguish each AA.  
 
Fig. 2: L-AAs can be linked together to form peptides and proteins. Amino and carboxyl group of 
AA can be linked together via peptide bond. Side chains (R) confers specific chemical properties to 
the peptide. From (Boron and Boulpaep 2005). 
 
 
Fig. 3: the 20 proteinogenic AA according to the IUPAC nomenclature. Taken from Nomenclature 
and Symbolism for Amino Acids and Peptides, (Recommendations 1976). 
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3.1.2 Amino acid functions and requirements 
Amino acids are crucial elements for life with a plethora of functions. As already mentioned, AAs 
serve as proteins building blocks and are essential for the production of functional proteins (e.g. 
enzymes, regulatory proteins and signal peptides) and for structural proteins (e.g. collagen and 
proteins of the cytoskeleton). Furthermore, free AAs play an important role in cell metabolism, as 
metabolic intermediates, in inter-organ communication, neurotransmission, regulation of gene 
expression, hormonal synthesis, oxidative defense, immune defense and acid-base balance (Grillo and 
Colombatto 2007; Kim and Wu 2009; Wu 2009). Representing 40-45% of total body weight, the 
skeletal muscles are the major reservoir of AAs. In fact, the body of a 70 kg man contains 
approximately 12 kg of protein (17%)  and 200 g of free AAs (0.3%) with a continuous exchange 
between both pools. The protein turnover was estimated to amount to approximately 300 g per day 
(Deutz, Wagenmakers et al. 1999). Since many free AAs are lost to energy conversion and urea, the 
daily requirement of dietary AAs amount to 70 g approximately (Deutz, Wagenmakers et al. 1999). 
Based on their specific requirement and on the ability (or not) to be sufficiently synthesized in the 
body, the 20 proteinogenic AAs were classified in essential (indispensible) and non-essential 
(dispensible) (Tab. 1). Furthermore AAs that can normally be synthesized by the organism, but need 
another AA as precursor, are classified as conditionally essential AAs. For example, Tyr can be 
synthesized in the liver and in the kidney by the enzyme phenylalanine hydroxylase (PAH), which 
however needs adequate amounts of starting substrate, Phe (Lichter-Konecki, Hipke et al. 1999). The 
classification might differ among species, due to different metabolism and food composition. 
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Essential AA Non-Essential AA Precursor 
Histidine Alanine  
Isoleucine Arginine
g
 Glutamine/ate, Aspartate 
Leucine Asparagine  
Lysine Aspartate  
Methionine Cysteine
b,c,g 
Methionine, Serine 
Phenylalanine Glutamate  
Threonine Glutamine
g 
Glutamate, Ammonia 
Tryptophan Glycine  
Valine Proline
b,g 
Glutamate 
 Serine  
 Tyrosine
c 
Phenylalanine 
 
Tab. 1: Essential and Non-essential AA in mammals and their respective precursor. Conditional 
essential AA are labeled with letters accordingly whether they are required under growth
g
, premature 
birth
b
 or cirrhosis
c
. Modified from (Gropper 2005; Wu 2009). 
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3.1.3 Amino acid metabolism and nutrition 
Besides proteins, a normal meal contains different components like sugars, fatty acids, vitamins, water 
and salts. Therefore it is fair to conclude that the body rarely faces a strict protein meal. Peters and 
Harper tested the effect of diets containing different levels of proteins and showed that several 
metabolic adaptations took place (Peters and Harper 1981; Peters and Harper 1985; Harper and Peters 
1989). In plasma, BCAA (Val, Ile and Leu) directly correlated with the dietary load, whereas Ala and 
Gln were hallmarks for low protein diets, similarly to starvation status. Interestingly, aromatic AA 
remained stable. Therefore the majority of free AA in plasma are maintained within normal 
concentrations and their excess can result in severe adverse effects like reduced food intake, abnormal 
behavior, impaired growth and death (Boron and Boulpaep 2005). The plasma concentration of each 
AA is the result of its rate of appearance (Ra) and disappearance (Rd) from plasma (Cynober 2002). 
The Ra is influenced not only by the dietary intake but also by the protein turnover and AA catabolism 
in different organs. Similarly, the Rd is influenced by the anabolism with the abduction in different 
organs and by body losses. Both rates are AA specific, especially the Rd because of different AA 
fates. Furthermore, differences were found between gender, age and body mass (Cynober, Blonde et 
al. 1983; Caballero, Gleason et al. 1991; Cals, Bories et al. 1994; Klassen, Furst et al. 2001). Other 
studies, in which AAs were administered in presence or absence of glucose, showed an ambivalent 
effect on insulin, glucose and AA concentrations (Gannon, Nuttall et al. 2002; Gannon, Nuttall et al. 
2002; Nuttall, Schweim et al. 2006; Kalogeropoulou, Lafave et al. 2008). Furthermore, it was shown 
that different protein loads and AA compositions of the diet affect the feeding behavior (Koehnle, 
Russell et al. 2003; Tome 2004; Langhans 2010). Thus, the correlation between dietary intake, 
metabolic status and AA plasma concentrations is extremely elaborate and appears to require complex 
network approaches to be understood (Bier 2003; Noguchi, Zhang et al. 2006; Shikata, Maki et al. 
2007).  
 
 
 
  3. Introduction 14 
 
 
 
Considering the simple case of a strict protein meal, the food is first homogenized mechanically in the 
mouth and subsequently digested in the gastrointestinal tract. Peptide bonds are cleaved by different 
peptidases present first in the stomach (i.e. pepsin) and afterwards in the small intestine (i.e. trypsin, 
chymotrypsin, carboxypeptidase and aminopeptidase). Specialized cells called enterocytes (epithelial 
layer) absorb, besides other nutrients, the free AA and the di/tri-peptides. These cells might use part of 
the AAs as energy source for own requirements or deliver the rest to the extracellular fluid (Boron and 
Boulpaep 2005; Gropper 2005; Wu 2009). The AAs that enter the blood stream have an obligatory 
passage through the liver via the portal vein, where the glucogenic AAs are captured and converted 
into pyruvate for glycogen production (Fig. 4). The other AAs, that are still present in the circulation, 
are used for protein synthesis by other tissues, especially in muscles.  
 
 
 
Fig. 4: Fate of AAs after a protein meal. From (Boron and Boulpaep 2005). 
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In contrast under starvation, the first priority is to maintain the glucose level constant for proper brain 
functionality, and only in a second instance to maintain protein reserves constant (Boron and Boulpaep 
2005; Gropper 2005). Thus, after an overnight starvation, three major adaptations are taking place: the 
Cori cycle, the glucose-alanine cycle and the lipolysis (Fig. 5). In the Cori cycle, the liver converts the 
lactate, which has been energetically produced from anaerobic metabolism, into glucose and releases it 
into the plasma. In the glucose-alanine cycle, muscles and splanchnic tissues release newly 
synthesized alanine and glutamine produced as a consequence of protein degradation into the blood. 
Afterwards, the two AAs are taken up by the liver and used for gluconeogenesis. Both cycles are thus 
used for energy transfer. Finally, the insulin drop causes the release from fat stores of fatty acids and 
glycerol that are used by the liver to further generate energy. Prolonged starvation moderates the 
proteolysis in muscles and accelerates lipolysis. 
 
Fig. 5: Adaptation after an overnight fast: Cori cycle, glucose-alanine cycle and lipolysis. From 
(Boron and Boulpaep 2005).  
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3.1.4 The metabolism of aromatic amino acids in mammals 
As discussed in section 3.1.1, the members of the aromatic AA group present an aromatic ring in their 
side chain and include phenylalanine, tryptophan, tyrosine and histidine. All of them can be 
considered as essential AA, since Tyr is dependent on Phe availability (Tab. 1). However, His differs 
from all other aromatic AA because its aromatic ring contains nitrogen (imidazole ring). This shows a 
pKa of approximately 6, thus gets protonated at pH lower than 6 where it has a positive charge 
(Fig. 3). As consequence of its peculiar chemical structure, His degradation differs from the other 3 
aromatic AAs: it might be catabolized into Glu, it might be combined with β-Ala to generate carnosine 
or it might be decarboxylated to form histamine (Gropper 2005). 
Of more interest are the other three aromatic AAs that display a benzyl ring (Phe, Tyr and Trp) and 
share a similar fate, being mostly degraded in the liver (Schimassek and Gerok 1965; Dietrich 1992; 
Brosnan 2003; Gropper 2005). Phe and Tyr are partially glucogenic and partially ketogenic, 
catabolized to acetoacetate. The first interconversion of Phe into Tyr is carried out by the enzyme 
phenylalanine hydroxylase (PAH), which was found in kidney and liver (Lichter-Konecki, Hipke et al. 
1999). The catabolism of Tyr is not strictly liver specific but many obligatory reactions for its 
degradation occur primarily in the liver. Besides, other tissues use Tyr to produce different important 
compounds. In neurons and adrenal medulla, Tyr is the precursor of L-dopa and catecholamines 
(dopamine, noradrenaline and epinephrine), that shows a half-life of a few minutes when circulating 
into the blood.  Furthermore, in melanocytes Tyr is transformed into melanin and in thyroid gland into 
thyroid hormones. Interestingly, the defect in Phe and Tyr metabolism (i.e. in the PAH enzyme) 
causes an autosomal genetic disorder named phenylketonuria, which results in a buildup of Phe and it 
derivates in the blood and causes neurologic disorders among others (Lichter-Konecki, Hipke et al. 
1999; Thony 2010; Kostandyan, Britschgi et al. 2011). Concerning Trp, approximately 95% of its 
metabolism takes place in the liver, where it is transformed to pyruvate or acetyl CoA for energy 
production. Important by-products of Trp degradation are niacin (vitamin B3) and NADP (Gropper 
2005; Yao, Fang et al. 2011). 
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 In addition Trp is used for the production of serotonin (5-HT), an important monoamine 
neurotransmitter (Lesch, Bengel et al. 1996), and melatonin, an hormone capable of influencing the 
daily cycle (Altun and Ugur-Altun 2007). Not surprising, an imbalance of Trp metabolism causes 
several disorders like α-ketoadipic aciduria (Przyrembel, Bachmann et al. 1975) and glutaric aciduria 
type I (Strauss, Puffenberger et al. 2003). 
 
In conclusion, if not used for the synthesis of protein, the aromatic AA (Phe, Tyr and Trp) are mainly 
degraded in the liver, which thus act as a sink and regulates their plasma concentration. As evidence of 
this role during cirrhosis, liver failure or liver resection, the aromatic AA accumulate in plasma 
(Dejong, van de Poll et al. 2007). Besides this main fate, other tissues use little portions of those AAs 
to produce important signal molecules, among them catecholamines and monoamines. Their 
imbalance causes several disorders.   
  3. Introduction 18 
 
 
 
 
3.2. Amino acid transport 
 
 
Dietary AAs must cross several barriers before reaching their final destination. First of all there is the 
intestine, where AAs are taken from the lumen and enter the blood stream. Furthermore, AAs in the 
blood stream might be filtered by the kidney, where they are reabsorbed. In both, intestine and kidney, 
specialized epithelia assure a proper trafficking. Finally, to reach the intracellular space of each cell, 
but also to pass through the epithelial cells, AAs need to cross the lipid bilayer of the cellular 
membrane, where they cannot freely diffuse and thus they need specialized proteins for their import 
and export. In the next subchapters these different aspects are more exhaustively explained, starting 
with the epithelial structure, continuing with the organization of gastrointestinal tract and kidney 
nephron, the membrane transport, the AA transporter proteins and finishing with particular families of 
AA transporters (i.e. Slc16 and Slc43). 
 
 
3.2.1 The epithelium 
The epithelium is composed of a specialized sheet of cells that form a tight barrier between the internal 
and the external milieux such that the organism can regulate its internal fluid and separate it from the 
variable and potentially toxic external environment. In order to achieve this goal, the epithelium can 
actively import and expel substances, sometimes even against a steep gradient. To form a dynamic 
barrier, the epithelium presents two characteristic features: a tight connection between cells (tight 
junction) and a polarization of its cellular membrane, which is divided into an apical and a basolateral 
part (Fig. 6).  
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The tight junctions limit the free diffusion of solutes and fluids and define the boundary between the 
apical and the basolateral membrane. It is a complex structure of parallel strands of closely packed 
particles (Fig. 6). The degree of impermeability is roughly proportional to the number of these strands 
and small molecules that can pass through are termed to take a paracellular diffusion (i.e. between 
cells). The principal structural elements are a family of proteins called claudins. Interestingly, tight 
junctions display tissue specific degrees of permeability and thus partially modulate the transport of 
some solutes. For example, in the renal proximal tubule the tight junction is quite leaky whereas in the 
thick ascending limb it is impermeable to water.  
 
The membranes separated by the tight junction present different proteins and lipid components on 
their surface that allow to enroll different functions. The apical membrane faces the lumen or 
extracorporeal world and generally presents typical infoldings also known as brush border, which 
amplifies the surface area in order to present more digestive enzymes and transport proteins. This is 
the case for intestinal cells, where the apical membrane forms microvilli and therefore increases the 
area by approximately 20 times. In contrast the basolateral membrane faces the inside of the body or 
the extracellular fluid compartment and is thus indirectly in contact with the blood. Other junctional 
complex types present in the lateral membrane interconnect the different cells and allow intercellular 
communication. The basolateral surface is also amplified by infoldings, however generally to a less 
extend than the apical one. Besides their morphological variance, the major difference relies in their 
protein composition, which also confers different biochemical properties. For example, in the intestine 
the apical membrane has to efficiently digest and import the different nutrients present in the lumen. In 
contrast, the basolateral membrane has to efficiently export the nutrients into the extracellular fluid 
and at the same time balance the import of other solutes that are necessary for cell survival and that are 
not present in the lumen. Importantly, in some tissues this process can work on the opposite way, like 
in the liver where toxic metabolites are sequestered from the blood and expelled into the bile. The 
proper trafficking and sorting of the different proteins in the appropriate membrane is thus crucial.  
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Fig. 6: Schema of an epithelium composed of polarized cells. The apical and the basolateral 
membrane are delimited by the tight junctions that connect the cells and limit the free diffusion of 
solutes and fluids. Other junction types are also illustrated. (Boron and Boulpaep 2005). 
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3.2.2 The gastrointestinal tract 
The gastrointestinal tract consists of a series of hollow organs that stretch from the mouth to the anus 
(Fig. 7A). Each of those organs covers a specialized function and is divided by the presence of 
sphincters. The mouth is responsible for chewing, lubricating the food and initiating carbohydrate and 
fat digestion.  
 
The stomach homogenate the food, secretes acids and initiates the protein digestion with the help of 
pepsins. The small intestine, which is divided into duodenum, jejunum and ileum, is the primary site 
for the absorption of nutrients. The large intestine reabsorbs fluid and electrolytes. Further accessory 
organs include the salivary glands, the pancreas and the liver. The liver is important for fat digestion, 
since it secretes the bile. In a second instance the liver also selectively removes from the circulation 
several freshly absorbed nutrients that obligatory pass through the portal vein. Thus, the liver plays 
also a key role in regulating plasma values of different components including the aromatic AA 
(see 3.1.4). The pancreas secretes several digestive enzymes and is important for the digestion of the 
protein and for the neutralization of gastric acids. The protein digestion is completed in the small 
intestine not only by the pancreatic enzymes but also by enzymes present in the brush border 
membrane.  
 
Anatomically the gastrointestinal tract varies along its length, however several structures are common 
(Fig. 7B). The internal part facing the lumen is the mucosa, which consists of epithelial cells (see 
3.2.1). Underneath there is the lamina propria, which contains capillaries, neurons and immune cells, 
and the lamina muscularis mucosae. Afterwards, the submucosa consists of loose connective tissue 
and larger blood vessels. Beneath, several layers of smooth muscles can be found (i.e. the muscularis 
externa) and enteric neurons. Finally, the serosa envelops the whole with connective tissues and 
squamous epithelial cells. A complex enteric nervous system controls the GI peristalsis via complete  
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reflex circuits. The small intestine presents a “villus – crypt” organization which enables to further 
increase the surface area (Fig. 8). Villi are finger-like projections of the mucosa and lamina propria 
where the epithelial cells are lined on. Together with the folds of Kercking and the microvilli, the villi 
enable to increase the surface area of approximately 600 folds compared to a simple cylinder. Thus, 
the total surface area of a human small intestine reaches approximately 200 m
2 
(Boron and Boulpaep 
2005). In contrast, the colon has more in crypts, thus its surface area is estimated in about 25 m
2
. 
 
 
 
Fig. 7: Organization of the gastrointestinal tract. A. The GI tract is composed by several hollow 
organs, divided by sphincters, and other accessory glands and organs. B. The wall of a generic 
segment consists of different structures among which the epithelium in the inside (mucosa), different 
layers of muscles and the serosa on the outside. From (Boron and Boulpaep 2005). 
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Fig. 8: The small intestine presents “villi – crypts” structures. A. Section of a duodenum with on 
top the villi (finger like-projections). B. Vertical section of a villus. C. Transverse section of a villus. 
From (Gray 1918). 
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3.2.3 The kidney 
The kidneys are paired bean shaped structures that lie behind the peritoneum and are responsible for 
three different functions: (1) to filter and remove unwanted metabolic products and toxins, (2) to 
regulate the fluids, electrolyte and acid-base balance and (3) to produce and activate different 
hormones. Together they account for less than 0.5% of the total body mass, but they receive a 
considerable amount of blood (up to 20% of the cardiac output). Their functional unit is the nephron, 
which consists of a glomerulus and a tubule (Fig. 9). Each human adult kidney consists of about 1 
milion of such nephrons (100’000 in mice). In the glomerulus, the afferent blood reaches a cluster of 
blood vessels where the plasma is filtrated and passes to the tubular system. The glomerular barrier 
consists of endothelial cells that forms fenestrated capillaries surrounded by the glomerular basement 
membrane and the podocytes. In a simplified view, 70 nm holes provide free passage of water and 
small solutes out of the vessels down in the tubule, whereas big particles like erythrocytes remains in 
the blood stream. The tubule is an epithelial structure with many subdivisions and different functions, 
as shown in Fig. 9. The first part, the proximal tubule, is further divided in two parts (proximal 
convoluted and proximal straight tubule). All parts present a brush border membrane and reabsorb the 
bulk of filtered fluid back in the circulation. Importantly, the proximal tubule is also the place where 
amino acids are reabsorbed, besides glucose, NaCl, NaHCO3, divalent ions and water. After the 
proximal tubule, the Henle’s loop, the thick ascending limb the distal tubule, the distal convoluted 
tubule, the connecting tubule and the final collecting duct are found. The tube of Henle concentrates or 
dilutes the ultrafiltrate, whereas the distal tubule and collecting duct system are responsible for the fine 
control of water and for the salt excretion.  
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Fig. 9: The kidney and its functional unit, the nephron. The different tubular parts are listed. 
(Boron and Boulpaep 2005) 
 
All solutes found in the urine come from the blood plasma perfused in the kidney. Thus, the rate at 
which the kidney excretes a solute equals the rate at which it disappears from the plasma, if the kidney 
does not produce or consume such a solute. Otherwise, the amount of solute excreted in the urine 
equals the sum of the amount filtered minus the amount reabsorbed and the amount secreted (Fig. 10). 
The clearance is plasma volume cleared of a substance in a given time (i.e. in ml / min), thus indicates 
the rate at which a substance is removed or cleared from the body by the action of kidneys and can be 
calculated with the formula Cx = (Ux x V) / Px where Cx is the clearance, Ux the urinary concentration 
of the substance X, V the volume of urine formed in a given time and Px the concentration of 
substance X in the plasma. The glomerular filtration rate (GFR) is the volume of fluid filtered in the  
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glomeruli per unit of time. The GFR can be extrapolated from the clearance of a known substance (e.g. 
inulin), provided that it is neither absorbed nor secreted. Knowing the GFR is important to extrapolate 
another useful parameter: the fractional excretion (FE). The FE is the ratio of the amount excreted in 
the urine to the amount of the filter load, or FEx = (Ux x V) / (Px x GFR), which is also the clearance to 
GFR ratio. In other words, the FE gives an indication if a solutes has been reabsorbed (if <1) or 
secreted (>1). The FE does however not reveal whether both occurred, but only the sum of both.  
 
 
 
Fig. 10: Factors that contribute to the net urinary excretion of a substance. (Boron and Boulpaep 
2005) 
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3.2.4 Membrane transport of small molecules 
As already mentioned earlier, hydrophilic solutes can poorly diffuse into the lipid bilayer of the 
cellular membrane. Therefore, specialized pathways mediated by integral membrane proteins are 
required for their cellular import and export. Three types of such pathways are recognized: (1) the 
pore, which is always open, (2) the channel, which is alternatively open and closed (thus a gated pore) 
and (3) the carrier, which has two transmembrane gates that are never open at the same time and which 
presents a translocation cycle (Fig. 11). The pores allow the passive movement of solutes and enhance 
the membrane permeability, whereas the channel allows the movement down to an electrochemical 
gradient. The flow through channels is controlled by the open probability of the channel via gating 
mechanisms and the single channel conductance. In contrast, the carriers have a fixed stoichiometry of 
movement per translocation cycle and each carrier protein shows a specific affinity for binding one or 
more solutes. The simplest passive carrier-mediated transport is the facilitated diffusion (Fig. 11A). 
The facilitated diffusion differs from a simple diffusion by its transport rate which gets saturated 
above a certain concentration and which thus presents a maximum (Fig. 11B). Coupled transporters 
carry two or more solutes in the same direction (e.g. B
0
AT1) and exchangers move them in opposite 
directions (e.g. Lat2-4F2hc) (Fig. 11A). All carriers that do not require ATP or coupled electron 
transport chain are members of the solute carrier (SLC) super-family. The SLCs are gatekeepers for all 
cells and organelles controlling the distribution of crucial compound such as sugars, nucleotides, ions, 
drugs and AAs. The Human Genome Organization (HUGO) provided a list of the SLC gene families, 
which were clustered upon their AA sequence homology (20-25% similitude among members) in 43 
groups for a total of 298 genes in 2004 (Hediger, Romero et al. 2004) (Tab. 2). The members of the 
same family therefore do not necessarily show the same transport modalities. The genes were named 
using the root symbol SLC followed by the number of the family (i.e. SLC1 – SLC43), the letter A (as 
divider except for a few families) and finally the number of the individual gene, thus for example 
SLC16A10 (TAT1). Nevertheless, it became more evident that other membrane protein families were 
not yet classified because of their unknown function. A website with the latest updates has been 
created (http://www.bioparadigms.org/slc/menu.asp). At present, there are 51 families and 378 genes 
and among those 7 are families that account AA transporters (Tab. 2 and Tab. 3). 
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Fig. 11: the different membrane transport modalities. A. A cell with solute carriers (SLC) and non-
SLC transporters expressed in its plasma membrane or in intracellular compartments. The different 
transport modalities of SLC members are also depicted (i.e. coupled transporter, exchanger and 
passive transporter). (Hediger, Romero et al. 2004). B. Transport rate upon solute concentration is 
different in a simple diffusion than in facilitated diffusion, where it is saturated and shows a half max 
flux. (Boron and Boulpaep 2005). 
 
 
Tab. 2: list of solute carrier (SLC) families and number of their members in 2004, the updated 
list can be visualized at the link www.bioparadigms.org/slc/menu.asp (Hediger, Romero et al. 2004).  
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3.2.5 The SLC16 gene family 
The SLC16 gene family accounts 14 members and is also known as the monocarboxylate 
cotransporter (MCT) family (Tab. 2). All family members are predicted to have 12 transmembrane 
domains, with intracellular N- and C-termini (Halestrap and Meredith 2004). The first four family 
members are known to transport important monocarboxylates such as lactate, pyruvate and ketone 
bodies. The other two characterized family members are MCT8 and MCT10, also known as XPCT 
and TAT1, respectively. MCT8 was shown to be a thyroid hormone transporter whereas TAT1 is the 
aromatic AA transporter (Friesema, Ganguly et al. 2003; Friesema, Jansen et al. 2005; Ramadan, 
Camargo et al. 2006). Interestingly MCT8 and MCT10 share 50% of homology in their sequence and 
are closely related to each other as opposed to other members (Fig. 12). Furthermore, they show a 
PEST sequence in their N-terminal (Fig. 13), which is thought to lead to rapid protein degradation 
(Rechsteiner and Rogers 1996). When tested, XPCT did however not mediate the transport of AA, 
whereas it is interesting to notice that both, TAT1 and XPCT, were able to mediate the transport of 
thyroid hormone triiodothyronine (T3) (Verrey, Ristic et al. 2005).  
 
 
 
Fig. 12: Predicted phylogeny of SLC16 gene family. tat1 (Slc16a10) and mct8 (Slc16a2) share 50% 
of homology. (Halestrap and Meredith 2004). 
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Fig. 13: Predicted topology of TAT1 with point mutation of tat1
-/-
 in position 88 (asterisk). 12 
transmembrane domains with intracellular N- and C- termini were predicted based on its AA sequence 
(Kim, Kanai et al. 2001) and on the predicted structure of MCT4 (Wilson, Meredith et al. 2005). The 
N-terminus presents a PEST sequence (orange). 
 
 
 
3.2.6 The SLC43 gene family 
The SLC43 gene family comprises 3 members: lat3 (Slc43a1), lat4 (Slc43a2) and eeg1 (Slc43a3) 
(Hediger, Romero et al. 2004; Broer 2008). When expressed in the oocyte heterologous system, lat3 
and lat4 mediated the facilitated transport of several neutral AAs, being however structurally different 
from other L-system transporters (Stuart, Pavlova et al. 2001). lat3 mRNA expression was confined to 
pancreas, skeletal muscles and liver (Babu, Kanai et al. 2003), whereas lat4 seemed to be expressed in 
kidney nephron and small intestine (Bodoy, Martin et al. 2005). eegl1 is an orphan transporter mostly 
expressed in fetus starting at embryonic day 7 but not during adulthood (Hediger, Romero et al. 2004). 
Furthermore eegl1 has not show amino acid transport properties so far. 
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3.2.7 Amino acid transporters 
The knowledge about the transport of AAs has evolved trough the past decades. Already at the 
beginning of 1900, Van Slyke and Meyer showed that AAs were absorbed from the blood to the 
tissues against a concentration gradient (Slyke and Meyer 1913). Afterwards, the pioneering work of 
Christensen in the early 1960 on tissue and cells, Heini Murer in the 1970 in membrane vesicles and 
Stevens in the 1980 allowed the classification of transport systems that were based on the 
physicochemical properties, stereospecificity, inhibition and selectivity (Christensen and Oxender 
1960; Murer, Evers et al. 1976; Stevens, Ross et al. 1982; Christensen 1990). Thus 3 distinct systems 
were found: 1) system that prefer Leu and large hydrophobic neutral AA (system L), 2) system that 
prefer Ala and small and polar neutral AA (system A) and 3) system that prefer Ala, Ser and Cys 
(system ASC) (Broer 2008) (Tab. 3). An attempt to simplify the nomenclature was suggested in 1984, 
when the symbols y
+
, x
-
 and 
0
 were proposed for basic, acidic and neutral transport systems and with 
additional letters indicating the substrate specificity. Sodium dependence was usually indicated by 
capital letter, although the previously characterized Na-independent system L was not modified (Broer 
2008). 
 
 In the 1990s the molecular identification and the cellular expression of the transporter has been 
possible. Thus, a further step in the characterization of the transport systems has been made (Kanai 
and Hediger 1992; Palacin, Estevez et al. 1998; Hediger, Romero et al. 2004; Verrey, Singer et al. 
2009). Usually, the system nomenclature was then followed by AT for AA transporter and a number 
for the different variants (e.g. Lat4; common names in Tab. 3). In particular, their function was studied 
in the heterologous Xenopous laevis expression system, by the injection of cRNA in the frog oocytes 
and by performing uptake and efflux studies with radiolabelled substrates. It has therefore also been 
possible to classify the AA transporters according to the SLC nomenclature (see 3.2.4, Tab. 3), which 
would be more preferable than the previous classification in systems that remained somehow 
inconsistent (Broer 2008). Furthermore, many AA transporters were localized by mean of specific 
antibodies. Lately, a few years  ago, the  function  of AA  transporters  has  been  further  analyzed  by   
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the determination of the protein structures (Verrey, Singer et al. 2009). However, the knowledge about 
the AA transporter cooperation has been slowed down by several technical difficulties such as the 
overlapping selectivity, the lack of selective inhibitors, the transport nature of obligatory and 
symmetrical exchangers (Verrey, Ristic et al. 2005). Although AA transport takes place in all cells of 
the body, the most well characterized transport machinery is the one of the mammalian kidney and 
intestine. Therefore, the AA transporters were also divided accordingly to their contribution to the 
apical uptake, basolateral efflux, housekeeping function or presence in other tissues (Tab. 3). 
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Transport  SLC Name 
Common 
Names Luminal Substrates Other Transported Species 
Apical Uptake   (System XAG)     
(1) SLC1A1 EAAT3 
EAAC1 
Anionic (or acidic) amino acids 
(Glu and Asp) 
Cotransports 2 Na+ and 1 H+ inward, 
exchanges 1 K+ outward (electrogenic 
uptake of net + charge) 
(2) Heterodimer: 
SLC7A9 
SLC3A1 
(System b0+) 
b0+AT 
rBAT 
Cationic (i.e., basic) amino 
acids (Lys+ or Arg+) or cystine 
(Cys-S-S-Cys) 
Exchanges for neutral amino acid 
(electrogenic uptake of + charge when 
substrate is Lys+ or Arg+) 
(3) SLC6A18-20 (System B or B0) 
B0AT1 
Neutral amino acids (not Pro), 
including aromatic amino acids 
(Phe, Trp, Tyr) 
Cotransports with Na+ 
(4) SLC36A1 PAT1 Pro, Ala, Gly, and imino acids 
Cytoplasmic substrates 
Cotransports with H+ 
Other transported species 
Basolateral Efflux 
(1) Heterodimer: 
SLC7A7 
SLC3A2 
(System y+L) 
y+LAT1 
4F2hc 
Cationic (i.e., basic) amino 
acids (Arg+, Lys+, ornithine+, 
His???) 
Exchanges for extracellular neutral 
amino acid plus Na+ (electrogenic 
uptake of + charge) 
(2) SLC16A10 TAT1 Aromatic amino acids (Phe, 
Trp, Tyr) 
None (facilitated diffusion) 
(3) Heterodimer: 
SLC7A8 
SLC3A2 
(System L) 
LAT2 
4F2hc 
Neutral amino acids Exchanges for neutral extracellular 
amino acid 
(4)   (System ASC) Ala, Ser, Cys, Thr Exchanges for extracellular neutral 
amino acid plus Na+ (electrogenic 
uptake of + charge) 
(Apical in SI) SLC1A4 
SLC1A5 
ASCT1 
ASCT2 
Basolateral substrates Other transported species 
Basolateral Uptake 
  
(System N)     
(5) SLC38A3 SNAT3 Gln, Asn, His Cotransports Na+ inward, exchanges 
H+ outward 
Amino Acid Transporters Present in Other Tissues 
  SLC1A2 
SLC1A3 
SLC1A6 
SLC1A7 
EAAT2, GLT-1 
EAAT1, GLAST 
EAAT4 
EAAT5 
Anionic (or acidic) amino acids 
(Glu and Asp) 
Cotransports 2 Na+ and 1 H+ inward, 
exchanges 1 K+ outward (electrogenic 
uptake of net + charge) 
  SLC6A1 
SLC6A11 
SLC6A12 
SLC6A13 
GAT1 
GAT3 
BGT1 
GAT2 
GABA (also betaine, β-alanine, 
taurine) 
Cotransports Na+ and Cl- 
    (System GLY) Glycine (also N-methylglycine, 
i.e., sarcosine) 
Pro 
Cotransports Na+ and Cl- 
Basolateral 
membrane in 
small intestine 
SLC6A9 
SLC6A5 
Pro 
GLYT1 
GLYT2 
PROT 
(System A) 
  Cotransports Na+ and Cl- 
Basolateral 
membrane in 
small intestine 
SLC38A1,2,4 
SLC38A3,5 
SNAT1,2,4 
(System N) 
Gln, Ala, Asn, Cys, His, Ser 
Flu, His, Hln, Asn, Ser 
Cotransports Na+ 
Cotransports Na+, exchanges H+ 
Apical 
membrane in 
small intestine 
SLC6A14 (System B0+) 
ATB0+ 
Neutral and cationic amino 
acids 
Cotransports Na+ and Cl- 
Tab. 3: Amino acid transporters. (Boron and Boulpaep 2005) 
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Several transport systems were identified through their involvement in the development of inherited 
disorders that displayed specific loss of AAs in the urine of patients (Verrey, Ristic et al. 2005; Broer 
2008). Among those Hartnup disorder, Cystinuria, Lysinuric protein intolerance, Blue diaper 
syndrome and Glycinuria. The luminal transport of AA has been more extensively studied in the past. 
One of the key players is the broad neutral AA transporter B
0
AT1 (SLC6A18), which transports the 
majority of free plasma AAs and whose defect causes the Hartnup disorder (Tab. 3 – 4, Fig. 14). Other 
known AA transporters are depicted in Fig. 14. The apical absorption of AA is driven by sodium or is 
proton mediated, thus it has been possible to measure their activity by electrophysiological 
approaches. Besides those luminal AA transporters, the di- and tri-peptide transporters, PEPT1 and 
PEPT2, exert a complementary role in the luminal AA uptake, in particular PEPT1, which is very 
important also in the intestine (Nassl, Rubio-Aliaga et al. 2011).  
 
As illustrated in Tab. 4, the majority of the inherited disorders leading to aminoaciduria were 
attributed to a defective apical transport. Therefore, less is known about the contribution of the 
basolateral transporter. The difficulty to produce membrane vesicles for the functional studies and the 
electroneutral transport of the solutes further limits the investigation. In the past, many authors have 
simply referred to the exit from the epithelial cell as an unavoidable quick passage, which should not 
become the limiting step. However, compartmental analysis of the movement of Lys across the small 
intestine showed that the rate limiting step was the exit across the basolateral membrane (Cheeseman 
1992). Furthermore, in order to preserve the cell, the basolateral membrane should not allow the total 
AA depletion but rather import nutrient from the blood in case of starvation. Thus, the basolateral 
membrane contains AA transporters important for the export but also housekeeping transporters that 
are found in other non-polarized cells (Fig. 14 and Tab. 3). It is well established that the two 
heterodimeric basolateral AA transporters, Lat2-4F2hc and y
+
Lat1-4F2hc, cannot directly mediate the 
net efflux of AA from the basolateral membrane, because they are obligatory exchangers and thus 
require  substrate  for a 1:1 exchange (Fig. 14). It was postulated that one or more facilitated  diffusion  
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pathway shall be present in the same membrane to allow the net efflux of at least some AAs that could 
then be exchanged for others (Verrey, Singer et al. 2009). It has also been shown with the X. laevis 
expression system that such a role can be mediated by tat1 (slc16a10) and that indeed its co-
expression allows the efflux of neutral AAs (Ramadan, Camargo et al. 2007). Furthermore, 
replacement of TAT1 by Lat4 and Lat2-4F2hc by Lat1-4F2hc, showed a similar functional 
cooperation. It became thus crucial to analyze the impact of the absence of those transporters in vivo, 
to better understand their functional cooperation.  
 
 
Tab. 4: Transport systems defined by inherited aminoacidurias. Most of the defects were 
attributed to the apical membrane transporters (Broer 2008). 
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Fig. 14: Cellular model of a kidney proximal tubule cell with the different apical and basolateral 
AA transporters. SLC and common names are depicted. Transported AAs are labeled in red (AA
-
 
means anionic AA, AA
0
 neutral and AA
+ 
cationic). (Verrey, Singer et al. 2009).  
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4. Material and Methods  
 
Luca Mariotta performed all the experiment described in this work, except for the microSPECT (4.1.7) 
that was done by Tony Lahoutte and Simone Camargo in the In vivo Cellular and Molecular Imaging 
Center Brussels. Furthermore lat4
-/-
 characterization (6.2.2) was partially done by Dong Wang and 
protein analysis under protein diet study (5.3.1) was done by Marta Torrente. Several experiments 
were done by Luca Mariotta in collaboration with Dustin Singer Brigitte Herzog and Adriano Guetg.  
 
 
4.1 Mice work 
 
4.1.1 tat1
-/-
 mouse 
The tat1 knock out mouse model was produced by Ingenium Pharmaceuticals AG (Germany) using 
the ENU (N-ethyl-N-nitrosurea) mutagenesis (Augustin, Sedlmeier et al. 2005; Keays, Clark et al. 
2006). The nonsense mutation in the tat1 gene leads to a premature stop at position 88 (Y88*). The 
mice were backcrossed 10 times in a C57Bl/6J inbred strain (Charles River, Germany), which was the 
background of the parental female, whereas the mutagenized sperm was C3HeBFeJ. Accordingly to 
the international ILAR News (1992) nomenclature the mice were named B6;C3-
(Slc16a10)mEug3(Y88*)Ingm.  
 
4.1.2 lat4
-/-
 mouse 
The lat4 knockout mice (lat4
-/-
) were generated at the Phenogenomic center of Toronto 
(http://www.phenogenomics.ca/). The mice were named accordingly to the ILAR identification 
B6;129-(SLC43A2)Gt(IST13572E12)Tigm. Cells of a repository clone (CMHD-GT_258C1) were 
identified to truncate lat4 gene at the 6
th
 intron with the insertion of a gene trap allele (UPA), as 
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described elsewhere (Shigeoka, Kawaichi et al. 2005). The ES cells were prepared for aggregation 
with diploid embryos to produce chimeric mice. R1 cells were in a 129 background, whereas germline 
testing was performed by crossing the chimera to CD-1 mice and assessing coat color. Subsequent 
breeding into C57BL/6 for the generation of F1 mixed animals. 
 
4.1.3 Tracking newborn development 
Breeding were set and male then separated 1 or 2 weeks after. Females were controlled daily until 
delivery. Afterwards, the litter was controlled twice a day. The compactness of the nest, the color of 
the skin of the pups and the milk spot were used as control parameters. Pups were labeled by daily 
coloring the extremities with a lab marker (Precision Dynamics Corporation, Secureline, USA). 
Weight of the pups was recorded daily. Between day 5 and day 9 of life, part of the 3
rd
 phalanx was 
cut and used for preparing gDNA with Phire Animal Tissue Direct PCR kit (Finnzymes, Thermo 
Scientific, CH) by using it accordingly to the manufacturer instruction.  
 
4.1.4 Genotyping 
tat1 were genotyped by a modified tetra primer arms PCR protocol (Ye, Dhillon et al. 2001). For the 
PCR reaction the following cycling profiles for Taq polymerase were used: 95°C 5 min; (95°C 60 sec; 
60.8°C 60 sec; 72°C 60 sec) x 35; 72°C 2 min; 10°C pause. The amplicons were detected on a 4% 
agarose gel where 3 bands were visible: 226, 195 and 87 basepairs. In the wt only the 226 and 195 
should be found, whereas the 226 and 87 for the tat1
-/-
. In the heterozygote all bands should be present. 
4 primers were used for tat1:  
 
A: 5’- GGG ACC CTC GGA TGT CTC -3’ 
 C: 5’- GTC GGT GTT TGG CAT CCA GAA CGC CAA A -3’ 
 D: 5’- GTG TCC AGC ATG GAC ACG AAG AGC ACC TGC -3’ 
 E: 5’- GGC CAT GTT GTC ATC GTC CTT GGC CTT GA -3’ 
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lat4 were genotyped by conventional PCR exploiting the following cycling profile for Taq 
polymerase: 95°C 5 min; (95°C 30 sec; 62°C 30 sec; 72°C 30 sec) x 35; 72°C 2 min; 10°C pause. Two 
amplicons should be detected in the heterozygote: 366 and 512 basepairs. The 366 bp band represent 
the wt allele and the 512 the lat4 knock out allele. The following primers were used for lat4: 
 
 WTF1: 5’- CTT CAT GAA TGG GTG AAT CTG CTC T -3’ 
WTR1: 5’- TAC AAC TGC AGG GGA TTC TAG TCC A -3’ 
MUTR1: 5’- ACC TGA AAT GAC CCT GTG CCT TAT T -3’ 
 
 
4.1.5 Different protein diets and metabolic cages 
10 week old tat1
-/- 
and wt littermate mice were fed sequentially with a normal protein diet (20% casein 
rich) followed by 8 days of high protein diet (40% casein rich). The modified standard diet AIN93G 
(Reeves, Nielsen et al. 1993) was maintained isocaloric by adjusting the starch content (Kliba-Nafg, 
Switzerland). Chow was put as pellet directly in the normal cages or reduced to powder for the 
metabolic cage experiment. Mice were daily weighed and put into metabolic cages (Tecniplast, 
Buguggiate, Italy) every third day from 0830 to 1630 to adapt, and 24 hours (0830-0830) at the end of 
each diet period. At the end of the 24 hours, urine and feces were collected and food and water 
consumption recorded. Urinary pH was measured using a pH microelectrode (691 pH-meter, 
Metrohm). Urinary creatinine was measured by the Jaffe method (Seaton and Ali 1984). Urinary and 
plasma urea were measured using the diacetyl monoxime method (Wybenga, Di Giorgio et al. 1971). 
Urinary electrolytes (Na
+
, K
+
, Ca
2+
, Mg
2+
, Cl
-
,  SO42
-
) were measured by ion chromatography 
(Metrohm ion chromatograph, Switzerland). Blood was collected through a single tail tip cut into Na-
heparinized micro-haematocrit-tubes (Provet AG, Switzerland) and plasma collected after 
centrifugation at 6000 g at 4°C. After animal sacrifice, organs were harvested, frozen in liquid 
Nitrogen and stored at -80°C. For amino acid measurements, organs were  lysed  using  MagNa  Lyser  
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Green Beads (Roche, Switzerland) in PBS supplemented with 1ul/ml Protease Inhibitor Cocktail 
(Sigma, Switzerland), in a ratio of wet weight to PBS volume of 1:3. Supernatant was collected after 
two 15’000 g centrifugations for 15’ at 4°C. 
 
4.1.6 RotaRod Test 
Mice were put on a rotating drum with an accelerating (day 1, 6 to 60 rpm) or fixed speed (day 2, 
average speed reached on day 1) (Sugiura, Kitagawa et al. 2005) (Ugo Basile, model 47600, Italy, 
courtesy of Dawid Wolfer lab). The time at which the animal drops off the drum was measured 
(maximal testing time: 300 s). Five trials were performed on each day. The average value of 4 
different attempts was calculated. 
 
4.1.7 Micro-SPECT 
The analysis was performed in the In vivo Cellular and Molecular Imaging Center Brussels as before 
(Lahoutte, Caveliers et al. 2002; Lahoutte, Mertens et al. 2003; Lahoutte, Caveliers et al. 2004; 
Bauwens, Lahoutte et al. 2007; Vanhove, Defrise et al. 2011). Briefly, 30 minutes after i.v. injection of 
either 2-
123
I-L-Phe or 2-
125
I-L-Phe (courtesy of ICMIC, Brussel), animals were anesthetized and their 
blood and organs collected. The activity was counted with a gamma counter.  Animals injected with 2-
123
I-LPhe could be anesthetized and imaged with a micro-SPECT (e.cam 180, Siemens) and a micro-
CT (Skyscan 1178, Skyscan, Belgium). Images were processed with the AMIDE 0.9.1 software 
(Loening and Gambhir 2003). 
 
4.1.8 GFR measurement 
Inulin clearance as measurement of the glomerular filtration rate (GFR) has been accordingly to 
Sällstrom and co-workers protocol (Sallstrom, Carlstrom et al. 2010). Briefly, animals were restrained 
and a 200 µL bolus injection of 
3
H-methoxy-inulin (ART0278, American Radiolabeled Chemicals 
Inc., USA) performed in the tail vein. The 
3
H-methoxy-inulin was priory divided into 5 µCi aliquots as 
decribed elsewhere (Shalmi, Lunau et al. 1991) in order to minimalise breakdown and consequent 
overestimations (Shalmi, Lunau et al. 1991). 5 µL tail vein blood was collected into heparinized 
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capillaries at different time points and plasma activity counted with scintillation counter. The 
clearance was calculated with the total AUC as described elsewhere (Qi, Whitt et al. 2004). 
 
4.1.9 Kidney microdissection 
All the procedures were performed by Dustin Singer as done before (Dustin Singer Diploma Thesis). 
Briefly, the mouse was anesthetized and ligations of abdominal aorta and vena cava twice posterior to 
kidney and once anterior to kidney prepared. After closure of the lowest ligation and after clamping of 
the abdominal aorta between kidney and ligation, a catheter was inserted in the aorta and legated. The 
clamp was opened, the renal artery cut and animals sequentially perfused with 8 ml DMEM/F12 and 8 
ml DMEM/F12 supplemented with liberase (57.14 µl in 10 ml). Afterwards, kidneys were excised, cut 
and further incubated in the DMEM/F12 liberase solution for 40 min. After three times washing with 
ice cold DMEM/F12 supplemented with BSA (300µg/ml), the segments were microdissected under 
binocular in the same washing solution. The collected tubules were put into 300 µl RLT Buffer and 
snap frozen in liquid nitrogen. mRNA was then extracted with RNeasy-Micro Kit (Quiagen) with a 
final elution of 14 µl of water. 
 
4.1.10 Everted gut sacs 
Uptake on first 2/3 of proximal small intestine segments of radiolabeled L-Phe and D-mannitol was 
performed as described elsewhere (Nassl, Rubio-Aliaga et al. 2011)). Brieﬂy, everted gut sacs were 
incubated for 10 minutes at 37°C in bubbling (Oxycarbon) Krebs-Tris buffer (pH 7.4) containing 100 
µM L-Phe, 0.5 µCi 
3
H-L-Phe/mL (Hartmann Analytic, Germany), 0.02 µCi 
14
C-D-Mannitol/mL 
(ARC, USA). After brief washing, sacs were cut open and content activity counted. Sacs were further 
dried at 55°C O/N on cellulose (Sartorius AG, Germany) and weighed. The sacs were lysed in 
Solvable (Perkin Elmer, Switzerland) for 6 hours at 50°C, bleached with 200µl of 30% H2O2, and the 
radioactivity was determined by liquid scintillation in 15 ml of Ultima Gold (Perkin Elmer, 
Switzerland). Amino acid transport was expressed relative to the dry tissue weight.  
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4.2 Other Analysis 
 
4.2.1 Amino acids measurement 
Ice-cold methanol deproteinization of samples was performed as described elsewhere(Suresh Babu, 
Shareef et al. 2002). Deproteinized samples or mouse urine were then derivatized using AccQ Tag 
(Waters, Milford, USA) and analyzed on an Acquity UPLC (Waters) according to the manufacturer’s 
instructions by the Functional Genomics Center Zurich (FGCZ) (Cohen and De Antonis 1994). 
Urinary creatinine was measured by the Jaffe method (Seaton and Ali 1984).  
 
4.2.2 Immunofluorescence and Real-time Quantitative PCR 
For tat1 immunofluorescence, the polyclonal anti-mTAT1 antibody was used as previously described 
(Ramadan, Camargo et al. 2006). For lat4, a new polyclonal rabbit anti-mLat4 (Pineda, DE) was 
generated against the C-terminal of Lat4 protein (immunizing peptide sequence: NH2-
CQLQQKREDSKLFL-CONH2) and affinity purified in SulfoLink column accordingly to the 
manufacturer instructions (Thermo Scientific, USA). B
0
AT1 antybodies were described before 
(Romeo, Dave et al. 2006; Singer, Camargo et al. 2009). For immunofluorescence the tissues were 
processed as described elsewhere (Rossier, Meier et al. 1999). Briefly, tissues were 5-7 µm cut with a 
cryotome (Leica, DE) and post fixed in cold MeOH for 90 s. Antigen was retrieved with a microwave 
eating in 10mM Na-Citrate pH 6.0 at 98°C for 10 min. Primary antibody were diluted 1:600 or 1:1000 
and incubated overnight at 4°C, whereas secondary 1:500 and incubated for 2 hours at RT.  
The mRNA was extracted with RNeasy kit (Qiagen, USA) and quantified with TaqMan kit (Applied 
Biosystems, USA) as described before (Ramadan, Camargo et al. 2006). 1 ng of cDNA was loaded in 
each reaction, in a final volume of 20 µl. 
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4.2.3 Statistics 
Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software, USA) and R 2.14 
(R Foundation of Statistical Computing). Unless mentioned otherwise, between-group comparisons 
were performed by Student's unpaired t-test or by repeated-measures one-way analysis of variance, 
followed by Bonferroni posttest. Statistical significance was accepted at P < 0.05 or as indicated. Data 
are presented as means ± SEM. 
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5. tat1 Mouse Model 
 
5.1 Introduction 
 
As discussed in the general introduction of this work (see 3.2.7), since the two well-known basolateral 
AA transporters, Lat2-4F2hc and y
+
Lat1-4F2hc, are obligatory exchangers they cannot directly 
contribute to the net basolateral efflux of AA in the epithelia. Thus, one or more facilitated diffusion 
pathway shall be present in the same membrane to allow the net efflux of at least one AA that could 
then be exchanged for others (Verrey, Singer et al. 2009). Previous work of Tamara Ramadan and co-
workers clearly show that such a role can be mediated by the aromatic AA transporter TAT1 
(Slc10a16): the co-expression of the facilitated diffusion pathway TAT1 and the exchanger Lat2-
4F2hc in the Xenopus laevis oocyte allowed the net efflux of several neutral AAs (Ramadan, Camargo 
et al. 2007). It was also shown that the two transporters co-localize in the same basolateral membrane 
of kidney proximal tubule cells and small intestine enterocytes. Thus, to better understand the role of 
tat1 in vivo in the epithelial efflux of AAs and to quantify its contribution to the basolateral transport 
machinery, a tat1 knock out mouse (tat1
-/-
) has been generated. The mouse was produced by Ingenium 
Pharmaceuticals AG by random mutagenesis with the introduction of a premature stop codon (Y88*) 
as depicted in Fig. 13 in 3.2.5 and M&M 4.1.1 for details. Therefore, the first question was about the 
role of tat1 in the epithelia in the context of the whole AA transport machinery. Furthermore, we 
investigated whether tat1 does impact on the neurological function, since it transports important 
precursors of neurotransmitters. Last, we controlled whether tat1 does impact on the systemic 
aromatic AA homeostasis.  
 
The results concerning the work on tat1
-/-
 are summarized in an original research article that is 
presented in the next section (5.2). Further data that were not shown in the manuscript are reported 
afterwards, in the addendum section (5.3).  
 5. tat1 Mouse Model 45 
 
 
 
 
5.2 Original research article: “T-type amino acid transporter TAT1 
(Slc16a10) is essential for extracellular aromatic amino acid 
homeostasis control” 
 
 
This manuscript summarizes the major finding about the characterization of the tat1 knock out mouse. 
The first major discover is the role mediated by tat1 in the flux of aromatic AA between plasma and 
liver, which in turn contributes to the control the aromatic AA homeostasis: when this is impaired the 
liver cannot anymore work as sink and thus aromatic AA accumulates in the blood. The second major 
issue is the role of tat1 in the epithelia. When TAT1 is missing there is not a major loss of AAs, when 
a normal diet is provided. Under high protein diet a spillover of neutral AAs in the urine is found, 
suggesting for the functional cooperation of TAT1 and Lat2-4F2hc. In the small intestine the transport 
is less affected by the lack of tat1. The last founding is the experimental proofs for an intracellular 
accumulation of AAs after tat1 depletion, which in turn blocks the apical import and results in AAs 
losses in the urine. The mild phenotype displayed by tat1 knock out mice also revealed that there must 
be at least another transporter that compensates TAT1 absence.  
 
The manuscript was submitted to the The Journal of Physiology on June 7
th
 2012.  
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Background: The amino acid transporter TAT1 
(Slc16A10) mediates facilitated diffusion of 
aromatic amino acids across membranes. 
Results: TAT1 null mice lack liver control of 
aromatic amino acids and display altered 
epithelial amino acid transport. 
Conclusion: TAT1 plays a central for the 
control body aromatic amino acid homeostasis. 
Significance: Equilibrative essential amino acid 
membrane transport controls amino acid 
homeostasis 
 
SUMMARY 
    The uniporter TAT1 (Slc16a10) mediates 
the facilitated diffusion of aromatic amino 
acids across basolateral membranes of kidney, 
small intestine and liver epithelial cells and 
across the plasma membrane of non-epithelial 
cells like skeletal myocytes. Its role for body 
amino acid homeostasis was now investigated 
using newly generated TAT1 (Slc16a10) 
defective mice (tat1
-/-
). These mice grow and 
reproduce normally, show no gross phenotype 
and no obvious neurological defect. 
Histological analysis did not reveal 
abnormalities and there is no compensatory 
change in any tested amino acid transporter 
mRNA. TAT1 null mice display however 
increased plasma, muscle and kidney 
aromatic amino acid concentration under 
both normal and high protein diet, although 
this concentration remains normal in liver. A 
major aromatic aminoaciduria and a smaller 
urinary loss of all substrates additionally 
transported by L-type amino acid antiporter 
Lat2-4F2hc (Slc7a8) were revealed under high 
protein diet. This suggests an epithelial 
transport defect as also shown by the 
accumulation of intravenously injected 
123
I-2-
I-L-Phe in kidney and of
 3
H-L-Phe in ex vivo 
everted gut sac enterocytes. Taken together, 
these data indicate that the uniporter TAT1 is 
required to equilibrate the concentration of 
aromatic amino acids across specific 
membranes. For instance, it enables 
hepatocytes to function as sink that controls 
the extracellular aromatic amino acid 
concentration. Additionally, it facilitates the 
release  of aromatic amino acids across the 
basolateral membrane of small intestine and 
proximal kidney tubule epithelial cells, 
thereby driving the efflux of other neutral 
amino acids via the parallel system L 
antiporter Lat2-4F2hc into the extracellular 
space. 
    Dietary and endogenous proteins are 
hydrolyzed in the gastrointestinal lumen to tri-
peptides, di-peptides and individual amino acids 
(AAs) that are taken up by small intestine 
enterocytes (Nassl, Rubio-Aliaga et al.). These 
cells hydrolyze the oligopeptides into single AAs 
and also further metabolize some of them. 
Finally, they release most AAs into the portal 
circulation, thereby strongly influencing the rate 
of AA appearance in plasma (Cynober 2002; Wu 
2009). It is noteworthy that the amount of free 
AAs transported daily from the enterocytes into 
the circulation is much larger than the free AA 
pool of the plasma and extracellular space (~100 
g per day versus less than 10 g), such that their 
uptake into tissues is crucial for maintaining 
extracellular AA homeostasis (Cynober 2002). In 
1 
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the cells of different organs, AAs may then serve 
as building blocks for the synthesis of structural 
and functional proteins, may be used for cellular 
metabolism or function as signaling molecules 
(Verrey, Singer et al. 2009; Wu 2009). 
Therefore, AA transfer across plasma 
membranes via various cooperating AA 
transporters plays a crucial role for body AA 
homeostasis and the defect of transporters leads 
to several diseases (Verrey, Singer et al. 2009; 
Broer and Palacin).  
    The best characterized basolateral AA 
transporters of the small intestine and proximal 
kidney tubule (re)absorbing epithelia are the 
abundant Lat2-4F2hc (Slc7a8) and y
+
Lat1-4F2hc 
(Slc7a7) that function as obligatory exchangers 
(antiporters). Thus, they do not mediate net AA 
transport, but are suggested to perform the 
directional transport of all their substrate AAs in 
exchange for AAs that can be recycled across the 
membrane by parallel transporters able to 
mediate a directional flux (Pfeiffer, Rossier et al. 
1999; Rossier, Meier et al. 1999; Meier, Ristic et 
al. 2002; Fernandez, Torrents et al. 2003; Verrey 
2003; Verrey, Singer et al. 2009). The role of 
Lat2-4F2hc has been recently investigated in 
vivo using a lat2 defective mouse (Braun, Wirth 
et al.). Its phenotype was mild, presenting an 
increase in several small neutral AAs in serum 
and a corresponding minor aminoaciduria. Based 
on this published data we estimate that the 
observed small urinary AA loss of lat2 null mice 
is not due to a decreased fractional excretion of 
AAs and therefore does surprisingly not point to 
a substantial epithelial AA transport defect 
(Braun, Wirth et al.). Interestingly, aromatic 
amino acids (AAAs) were not elevated in the 
serum of lat2 null mice, suggesting that another 
AA transporter plays here a dominant role, 
possibly the T-type aromatic AA transporter 
TAT1 (Slc16a10) which was found slightly 
upregulated in the kidney of lat2 null animals. 
This transporter was molecularly identified and 
first characterized in 2001 by Endou and 
coworkers (Kim, Kanai et al. 2001). In a later 
study, we have demonstrated using the Xenopus 
laevis oocyte expression system that TAT1 
functions as a facilitated diffusion pathway 
which mediates the transport of AAAs L-Phe, L-
Trp and L-Tyr with symmetric low apparent 
affinities, for instance with a K0.5 of 
approximately 30 mM for L-Phe influx and 
efflux (Ramadan, Camargo et al. 2006). 
Interestingly, TAT1 protein was shown to co-
localize in the kidney proximal tubule with the 
two exchangers mentioned above (Ramadan, 
Camargo et al. 2007) and also to localize to the 
basolateral membrane of small intestine 
enterocytes and the sinusoidal membrane of 
perivenous hepatocytes (Ramadan, Camargo et 
al. 2006). The analysis of tat1 mRNA expression 
by real time PCR revealed its presence in the 
epithelial tissues mentioned above and also in 
muscles and brain (Ramadan, Camargo et al. 
2006). Finally, it was demonstrated that AAAs 
effluxing via TAT1 can be recycled into the cell 
by the exchanger Lat2-4F2hc and thereby drive 
the efflux of other intracellular neutral AAs that 
are substrates of Lat2-4F2hc (Ramadan, 
Camargo et al. 2007). To investigate the role that 
TAT1 plays in whole body AA homeostasis 
maintenance and in epithelial AA transport, we 
generated a TAT1 knock out (tat1
-/-
) mouse and 
present here its first characterization. 
 
EXPERIMENTAL PROCEDURES 
The tat1 knock out mouse model was produced 
by Ingenium Pharmaceuticals AG (Germany) 
using ENU (N-ethyl-N-nitrosurea) mutagenesis 
(Augustin, Sedlmeier et al. 2005; Keays, Clark et 
al. 2007). The nonsense mutation in the tat1 gene 
leads to a premature stop at position 88 (Y88*). 
The mice were backcrossed 10 times in a 
C57Bl/6J inbred strain (Charles River, 
Germany), which was the background of the 
parental female, whereas the mutagenized sperm 
was C3HeBFeJ. All animals were housed in 
standard conditions in normal light cycle and fed 
a standard diet prior to experiment. All 
procedures for mice handling were according to 
the Swiss Animal Welfare laws and approved by 
the Kantonales Veterinäramt Zürich.  
    Immunofluorescence and real-time PCR. The 
anti-mTAT1 antibody used has been previously 
characterized (Ramadan, Camargo et al. 2006) 
and tissues were processed as described 
elsewhere (Rossier, Meier et al. 1999). mRNA 
was extracted and quantified as described before 
(Ramadan, Camargo et al. 2006). 
    RotaRod Test. Mice were put on a rotating 
drum with an accelerating (day 1, 6 to 60 rpm) or 
fixed speed (day 2, average speed reached on day 
1) (Ugo Basile, model 47600, Italy) (Sugiura, 
Kitagawa et al. 2005). The time at which the 
animal drops off the drum was measured 
(maximal testing time: 300 s). Five trials were 
performed on each day. The average value from 
4 different experimental days was calculated. 
    Different protein diets and metabolic cages 
experiments. Ten week old tat1
-/- 
and wt 
littermate mice were fed sequentially with a 
normal protein diet (20% casein) followed by 8 
2 
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days of high protein diet (40% casein). The 
modified standard diet AIN93G was maintained 
isocaloric by adjusting the starch content (Kliba-
Nafg, Switzerland). Chow was put as pellet 
directly in the normal cages or reduced to 
powder for the metabolic cage experiment. Mice 
were daily weighed and put every third day into 
metabolic cages (Tecniplast, Buguggiate, Italy) 
from 08:30 to 16:30 to adapt, and 24 hours 
(08:30-08:30) at the end of each diet period. At 
the end of the 24 hours, urine and feces were 
collected and food and water consumption 
recorded. Urinary pH was measured using a pH 
microelectrode (691 pH-meter, Metrohm). 
Urinary creatinine was measured by the Jaffe 
method (Seaton and Ali 1984). Urinary and 
plasma urea were measured using the diacetyl 
monoxime method (Wybenga, Di Giorgio et al. 
1971). Urinary electrolytes (Na
+
, K
+
, Ca
2+
, Mg
2+
, 
Cl
-
, SO4
2-
) were measured by ion 
chromatography (Metrohm ion chromatograph, 
Switzerland). Blood was collected through a 
single tail tip cut into Na
+
-heparinized micro-
haematocrit-tubes (Provet AG, Switzerland) and 
plasma collected after centrifugation at 6000 g at 
4°C. After animal sacrifice, organs were 
harvested, frozen in liquid nitrogen and stored at 
-80°C. For AA measurements, organs were lysed 
using MagNa Lyser Green Beads (Roche, 
Switzerland) in PBS supplemented with 1 µl/ml 
Protease Inhibitor Cocktail (Sigma, Switzerland), 
in a ratio of wet weight to PBS volume of 1:3. 
Supernatant was collected after two 15’000 g 
centrifugations for 15 minutes at 4°C. 
    Amino acids measurement. Ice-cold methanol 
deproteinization of samples was performed as 
described elsewhere (Suresh Babu, Shareef et al. 
2002). Deproteinized samples or mouse urine 
were then derivatized using AccQ Tag (Waters, 
Milford, USA) and analyzed on an Acquity 
UPLC (Waters) according to the manufacturer’s 
instructions by the Functional Genomics Center 
Zurich (FGCZ) (Cohen and De Antonis 1994). 
The tat1
-/-
 plasma AA ratios represented in Fig. 
3B were normalized to the wt ones that were 
measured within the same diet and that are 
directly depicted in Fig. 3A. The same procedure 
was used to obtain the normalized urinary values 
depicted in Fig. 5B.  
    Micro-SPECT/CT imaging and biodistribution 
analysis. Imaging and biodistribution of the 
aromatic amino acid analog 
123
I-2-I-L-Phe was 
performed in wt and tat
-/-
 mice. 
123
I-2-I-L-Phe 
was synthetized as decribed before (Bauwens, 
Lahoutte et al. 2007). Animals injected with 
123
I-
2-I-L-Phe were anesthetized and imaged 30 min 
after i.v. injection with a micro-SPECT (e.cam 
180, Siemens) and a micro-CT (Skyscan 1178, 
Skyscan, Belgium) system as described before 
(Lahoutte, Caveliers et al. 2002; Lahoutte, 
Mertens et al. 2003; Lahoutte, Caveliers et al. 
2004; Bauwens, Lahoutte et al. 2007; Vanhove, 
Defrise et al.). Images were visualized with the 
AMIDE 0.9.1 software, where MicroCT is 
represented in gray scale and MicroSPECT in 
NIH color scale (Loening and Gambhir 2003). 
After imaging, animals were sacrificed and 
dissected. All major organs and tissues were 
collected and counted in a gamma camera 
counter (Canberra, Belgium) and expressed as 
percentage of injected activity per gram of organ 
or tissue. 
    Everted gut sacs. Uptake on first 2/3 of 
proximal small intestine segments of 
radiolabeled L-Phe and D-Mannitol was 
performed as described elsewhere (Nassl, Rubio-
Aliaga et al.). Brieﬂy, everted gut sacs were 
incubated for 10 minutes at 37°C in bubbling 
(Oxycarbon) Krebs-Tris buffer (pH 7.4) 
containing 100 µM L-Phe, 0.5 µCi 
3
H-L-Phe/mL 
(Hartmann Analytic, Germany), 0.02 µCi 
14
C-D-
Mannitol/mL (ARC, USA). After brief washing, 
sacs were cut open and content activity counted 
(serosa). Sacs were further dried at 55°C O/N on 
cellulose (Sartorius AG, Germany) and weighed. 
The sacs (tissue) were lysed in Solvable (Perkin 
Elmer, Switzerland) for 6 hours at 50°C, 
bleached with 200 µl of 30% H2O2, and the 
radioactivity was determined by liquid 
scintillation in 15 ml of Ultima Gold (Perkin 
Elmer, Switzerland). AA transport was expressed 
relative to the dry tissue weight.  
    Statistics. Statistical analysis was performed 
using GraphPad Prism 5.0 (GraphPad Software, 
USA) and R 2.14 (R Foundation of Statistical 
Computing). Unless mentioned otherwise, 
between-group comparisons were performed by 
Student's unpaired t-test or by repeated-measures 
one-way analysis of variance, followed by 
Bonferroni posttest. Statistical significance was 
accepted at P<0.05 or as indicated. Data are 
presented as means ± SEM. 
 
RESULTS 
A tat1 knockout mouse (tat1
-/-
) was produced by 
ENU mutagenesis (Ingenium Pharmaceuticals 
AG, Germany) in the context of the former 
European EUGINDAT project. The nonsense 
mutation (Y88*) was confirmed by DNA 
sequencing and the mice were backcrossed 10 
times into C57Bl/6J background. Absense of tat1 
expression was confirmed using 
3 
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immunofluorescence and mRNA analysis. The 
TAT1 protein was indeed not detected in any of 
the knock out samples tested (Fig. 1, B and D) 
and the tat1 mRNA levels were decreased in all 
tested tissues, but in white adipose tissue (Suppl. 
Tab. 1a and b, tat1), presumably due to non-
sense mediated decay (Maquat 1995). 
    Mild phenotype under normal conditions.  
tat1
-/- 
pups grew normally and showed no visible 
phenotype when compared to their wild type (wt) 
littermates (Suppl. Fig. 1). Once adult, tat1
-/-
 
mice showed no body weight difference 
compared to wt (Tab. 1), they were fertile and 
gave birth to normal litters matching the 
expected mendelian distribution (data not 
shown). AAAs transported by TAT1 such as L-
Trp and L-Tyr are known to be precursors of 
serotonine, catecholamines and thyroid hormone. 
Thus, the absence of TAT1 transporter could 
potentially impact on neurotransmitter and 
thyroid hormone availability and lead to 
neurological disorders. Although no gross 
behavioral change was observed, the motor 
activity and coordination skills of the mice were 
tested using a RotaRod test (Karl, Pabst et al. 
2003), which however showed no difference 
between tat1
-/- 
and wt littermates (Fig. 2). In an 
attempt to exacerbate a potential phenotype, the 
same experiment was carried out after subjecting 
the mice to a 7% casein diet for 5 days, without 
revealing any difference between the two groups 
(data not shown). In order to visualize a potential 
abnormal behavior, the animals were as well 
video recorded in their normal cage prior and 
after fasting (data not shown) and their feeding 
and drinking behavior recorded for 24 hours in 
metabolic cages (Tab. 1). Again, no difference 
was observed between tat1
-/-
 mice and their wt 
littermates. A histological analysis of kidney, 
liver and intestinal segments on hematoxylin 
eosin stained sections did also not reveal any 
abnormality (Suppl. Fig. 2). A possible 
upregulation of other AA transporters was then 
investigated as compensatory mechanisms for 
TAT1 absence, but no significant change was 
noticed at the level of any tested AA transporter 
mRNA (Suppl. Tab. 1a and b). Also the 
carbohydrate metabolism did not appear to be 
perturbed, as indicated by a normal oral glucose 
tolerance test (Suppl. Fig. 3).  
    Altered homeostasis of aromatic amino acids. 
To assess the general impact of TAT1 absence 
on AA homeostasis, we measured the plasma 
concentration of proteinogenic AAs. 
Surprisingly, 
 
the AAA plasma concentration of 
tat1
-/-
 mice was 2, 3 and 7.5 times higher than in 
wt for L-Phe, L-Trp and L-Tyr, respectively 
(Fig. 3B). In contrast, many other AAs were 
significantly diminished in tat1
-/-
 plasma (i.e. 
Gly, L-Ala, L-Met, L-Ser, L-Thr, L-Asn, L-Gln, 
L-Lys and L-Arg). In view of the mild general 
phenotype observed under normal protein diet 
(20%), the animals were challenged for 8 days 
with a high protein diet (chow containing 40% of 
casein). This treatment did not significantly 
affect their body weight and, besides the 
expected high creatinine and urea excretion, only 
an increased fluid intake probably due to the 
texture of the chow was observed (Tab. 1 and 
Suppl. Tab. 2). tat1
-/-
 mice displayed similar 
values as their wt littermates with a more 
pronounced effect on fluid intake. Upon switch 
to high protein diet, the plasma AAs remained 
stable in wt animals with the exception of the 
branched chain ones (BCAAs) that increased 
(Fig. 3A). In tat1
-/-
 mice, the diet had a similar 
effect as in wt mice and maintained the peculiar 
pattern observed under normal diet: an elevated 
concentration of AAAs and a low concentration 
of all other AAs, except the BCAAs, which 
followed the dietary effect observed in the wt 
(Fig. 3B).  
To further investigate the cause of the AA 
imbalance, free cytosolic AAs were measured in 
organs that represent the major reservoirs and 
metabolic sites: kidney, liver and skeletal 
muscles. The cellular concentrations of 5 
representative AAs are depicted in Fig. 4. The 
AAAs L-Tyr and L-Trp displayed values strictly 
parallel to plasma in kidney and skeletal muscle. 
In contrast, in liver AAAs remained at the same 
lower concentration in tat1
-/-
 as in wt. The organ 
concentrations of all non-aromatic AAs were 
similar in tat1
-/-
 as in wt animals, as shown for L-
Val and L-Leu (Fig. 4). One peculiarity is the 
high L-Phe values measured in kidney. This 
value might be related to the role of the kidney 
for the production of L-Tyr from L-Phe. 
    Altered epithelial amino acid transport. The 
analysis of 24 hours urine collected in metabolic 
cages showed that the dietary switch did not 
affect the AA excretion in wt animals (Fig. 5A). 
tat1
-/- 
mice presented an aromatic aminoaciduria 
under normal protein diet that paralleled the high 
plasma values (Fig. 5B). However, under high 
protein diet, L-Tyr was found to be 64 times 
more abundant in tat1
-/-
 than in wt urine and L-
Trp and L-Phe, 95 and 9 times, respectively. 
Furthermore, many other neutral AAs were also 
present in higher amounts in tat1
-/-
 urine (i.e. 
between 2 and 9 fold), including all other 
substrates of the Lat2-4F2hc broad selectivity 
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neutral AA exchanger. This indicates that under 
normal protein diet tat1
-/-
 mice had an almost 
normal or only slightly increased fractional 
excretion of all AAs. In contrast, the high protein 
diet provoked in tat1
-/-
 mice a high urinary 
excretion of AAs corresponding to a major 
increase of their fractional excretion. This 
decompensation of kidney AA reabsorption was 
selective, since all other measured urinary 
parameters did not display any significant 
difference between tat1
-/- 
and wt control mice 
(Tab. 1). 
Since TAT1 is expressed in the basolateral but 
not in the apical membrane of kidney proximal 
tubule, we hypothesize that the observed 
aminoaciduria might derive from an impaired 
basolateral export rather than from a defective 
apical import into epithelial cells. To verify this 
hypothesis, we used the isotopes 
123
I-2-I-L-Phe 
and 
125
I-2-I-L-Phe. These iodinated AAs are used 
as markers for oncologic imaging outside the 
brain, since their accumulation reflects the 
increased AA transport activity of cancer cells 
(Jager, Vaalburg et al. 2001; Lahoutte, Mertens 
et al. 2003). Their biodistribution has already 
been assessed and their validity demonstrated 
(Lahoutte, Caveliers et al. 2001; Lahoutte, 
Mertens et al. 2003; Lahoutte, Caveliers et al. 
2004). When tested in the Xenopus laevis 
oocytes expression system, the compound (2-I-
L-Phe) was shown to efficiently compete for L-
Phe transport, whether mediated by TAT1, Lat4 
(Slc43a2) or Lat2-4F2hc (Suppl. Fig. 4). 
Exploiting microSPECT/CT technique, the 
123
I-
2-I-L-Phe isotope was used for live imaging of 
its distribution 30 minutes after i.v. injection 
(Fig. 6). Indeed a higher accumulation of the 
compound was clearly detected in both kidneys 
of the tat1
-/-
 mouse (Fig. 6B). This qualitative 
observation was verified by the quantification of 
the accumulated counts after sacrifice (n = 3; 
Fig. 6C).  
Since as in kidney proximal tubule, TAT1 is also 
expressed in the basolateral membrane of 
epithelial cells along the small intestine 
(Ramadan, Camargo et al. 2006) (Suppl. Tab. 1), 
AA transport was measured in everted gut sacs. 
A significant accumulation of 
3
H-L-Phe was 
observed in the enterocytes after 10 minute 
incubation at 37°C (Fig. 7). Also a tendency for 
decreased net transepithelial transport into the 
serosal compartment was observed. This data 
support the hypothesis that TAT1 absence 
reduces the transepithelial transport of AAAs by 
decreasing their basolateral efflux. 
 
DISCUSSION 
Although the lack of TAT1 does not prevent the 
normal development and fertility of mice, the 
study of the newly developed tat1
-/-
 mouse 
revealed a number of important functions of this 
low affinity AAA uniporter that impact on body 
AA homeostasis. For instance, the disruption of 
TAT1 is shown to prevent the liver of playing its 
central role for the metabolism of AAAs. It is 
indeed well known that the accumulation of AAs 
as response to high protein diet is counteracted 
by an increase in liver AA catabolism 
(Moundras, Remesy et al. 1993). In particular, 
the liver is the major metabolic organ for the 
catabolism of AAAs (Schimassek and Gerok 
1965; Brosnan 2003) and its failure causes an 
increase of AAAs in plasma (Fischer, Rosen et 
al. 1976; Brosnan 2003). This leads to a decrease 
of the BCAAs / AAAs ratio (Fischer ratio) and 
the consecutive increase of AAA uptake into the 
brain has been suggested to be a major cause of 
hepatic encephalopathy (James, Ziparo et al. 
1979; Dejong, van de Poll et al. 2007). Here we 
show that plasma AAAs are stably elevated in 
tat1
-/-
 mice regardless of the dietary load (Fig. 3). 
This increase is reflected in skeletal muscles, 
suggesting that TAT1 is not necessary for the 
AAA equilibration between plasma and this 
compartment (Fig. 4; Suppl. Tab. 1b). In 
contrast, in the liver of tat1
-/-
 mice the 
intracellular AAA values are normal, indicating 
that the transport between the plasma that 
contains an elevated AAA concentration and this 
organ is uncoupled. The present data document 
that tat1 mediates the equilibration of the 
extracellular AAA concentration with the 
hepatocytes and suggests that the liver functions 
as sink for the AAAs and thereby sets their 
concentration and controls their body 
homeostasis.  
AAAs play important roles in the brain and both 
increased and decreased levels are thought to 
impair brain function, as mentioned above for 
the increase in AAAs due to liver failure that 
contributes to hepatic encephalopathy. An 
example in which a decreased level of AAAs 
leads to an alteration of brain functions is that of 
dietary L-Trp restriction that was shown in mice 
to result in altered emotional response to stress 
and increased locomotor activity (Uchida, 
Kitamoto et al. 2005). However, a more recent 
study did not find a correlation between L-Trp 
depletion, central serotonin reduction and 
affective behavioral changes (van Donkelaar, 
Blokland et al.). The lack of hepatic 
encephalopathy or behavioral disorders in tat1
-/-
, 
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suggests that the AAA concentration within the 
brain is maintained by the intact blood brain 
barrier at a level that has no gross functional 
consequences. Because tat1 is not expressed in 
mouse blood brain barrier, it is not likely that the 
protection of the brain of tat1 null mice is due to 
the lack of tat1 expression (Lyck, Ruderisch et 
al. 2009). 
In the light of the mild phenotype and normal 
growth of tat1
-/-
 mice, it appears that these mice 
maintain the capacity to absorb AAs from 
nutritional sources. This indicates that intestinal 
AA absorption and in particular the basolateral 
efflux of (aromatic) AAs from enterocytes is 
possible also in the absence of TAT1. Yet 
another cellular barrier that expresses TAT1 but 
in which this transporter appears to be 
dispensable in laboratory conditions is the 
placenta (Meredith and Christian 2008). Indeed, 
tat
-/-
 fetus develop normally and tat1
-/-
 female 
mice are normally fertile. We therefore tested 
whether some other transporters that could 
compensate for the lack of TAT1 would be 
induced. However, none of the other basolateral 
neutral AA transporters was found to be 
upregulated at the mRNA level in intestine and 
kidney, suggesting that the residual AAA 
transport capacity and potential paracellular 
transport can compensate for tat1 absence under 
normal diet.  
An important finding is the massive loss of 
AAAs and more discrete loss of all substrate 
AAs of the neutral exchanger Lat2-4F2hc in the 
urine of  tat1
-/-
 mice under high protein diet (Fig. 
5). This aminoaciduria implies that the maximal 
transport capacity for these AAs was exceeded in 
kidney proximal tubule and reveals the role of 
TAT1 for epithelial amino acid transport. 
Furthermore, it is suggested that this (aromatic) 
AA loss explains the fact that the tat
-/-
 mouse 
plasma AA concentration does not additionally 
change much under high protein diet. In our 
assay the urine was collected over 24 hours, 
whereas the blood was collected once (i.e. 3 
hours after the switch to the inactive light phase). 
It is thus conceivable that under normal protein 
diet the AA transport rate is near the maximal 
transport capacity of the proximal tubule, already 
within the so-called splay, where some nephrons 
have not the capacity of reabsorbing all 
substrates. Since the plasma AA levels depend 
also on nutritional intake and are higher during 
the absorptive phase, under high protein diet a 
transient increase in blood AAs might cause the 
AA spillover. The urinary AA pattern (very high 
TAT1 substrates, increased Lat2-4F2hc 
substrates) is in line with the suggested 
functional cooperation of the uniporter TAT1 
with the exchanger Lat2-4F2hc for the net efflux 
of neutral AAs, as previously shown in the 
Xenopus laevis expression system (Ramadan, 
Camargo et al. 2007). Interestingly, the loss of 
L-Phe in the urine was lower than that of L-Tyr 
and L-Trp. We hypothesize that this is due to the 
ability of another basolateral uniporter to 
transport L-Phe. Indeed, we have shown that 
Lat4 (Slc43a2) is also localized in the basolateral 
membrane of proximal kidney tubule cells and of 
small intestine enterocytes (Bodoy, Martin et al. 
2005) (Mariotta, Guetg and Verrey unpublished 
data). This transporter was first described by 
Bodoy et al. in 2005 and shown to mediate the 
facilitated diffusion of BCAAs, L-Met and L-
Phe and to a lesser extend L-Pro, L-Tyr and L-
Trp. The presence of this other uniporter for 
essential amino acids and its selectivity might 
explain the differential urinary AAA pattern 
observed in tat1
-/-
 mice (9-fold more L-Phe 
versus 64 and 95-fold more L-Tyr and L-Trp, 
respectively). Furthermore, Lat4 could to a large 
extent compensate for the absence of TAT1 in 
kidney and intestine and thus explain the mild 
phenotype of tat1
-/-
 mice. The lack of Lat4 
expression in the liver does on the other hand 
explain the fact that in the absence of tat1 
expression, the liver cannot function as sink for 
aromatic amino acids (Bodoy, Martin et al. 
2005). 
To verify that AAAs are efficiently imported 
luminally into transporting epithelial cells of 
tat1
-/-
 mice, where they accumulate due to their 
inefficient basolateral export and consequently 
inhibit the apical transport, in vivo 
microSPECT/CT and ex vivo everted gut sac 
experiments were performed. The results 
confirmed the accumulation of tracers inside the 
epithelial cells (Fig. 6 and 7). However, the 
everted gut sacs experiments did not allow us to 
detect a significant difference in the net 
transcellular flux of L-Phe (Fig. 7: Serosa). This 
was due to a substantial residual permeability of 
the small intestine epithelium of tat1
-/-
 mice for 
AAAs that might explain the normal growth of 
tat1
-/- 
mice. This residual permeability is 
presumably due to a large extent to the 
contribution of the other uniporter Lat4, as 
mentioned above. We hypothesize however that 
a paracellular leak might also contribute to this 
permeability, as previously suggested for glucose 
and phosphate (Danisi and Murer; Pappenheimer 
1993; Ballard, Hunter et al. 1995). 
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A defect in tat1 has been predicted to be the 
cause of the blue diaper syndrome (Kim, Kanai 
et al. 2001; Broer 2008; Broer and Palacin). This 
syndrome was initially described by Drummond 
and co-workers in 1964 and appears to be caused 
by an excess of unabsorbed L-Trp in the 
intestinal tract (Drummond, Michael et al. 1964). 
We did not observe any symptom reminiscent of 
this syndrome in tat1
-/- 
mice. Furthermore the 
amount of L-Trp found in the distal part of the 
small intestine was similar to wt (Suppl. Fig. 5) 
and much less than observed in Hartnup disorder 
(Singer and Verrey, unpublished results). 
 
In summary, the analysis of tat1
-/-
 mice 
confirmed that a complex machinery of AA 
transporters functionally cooperates for the 
absorption and distribution of dietary AAs. Our 
data further indicate that TAT1 exerts a major 
homeostatic function by equilibrating the 
concentration of AAAs between plasma and 
hepatocytes, where the AAAs are in turn 
catabolized. The functional impact of TAT1 
absence becomes more evident under high 
protein diet, when the transport capacity of the 
kidney is exceeded such that a massive aromatic 
and also a neutral aminoaciduria appear that 
contributes in maintaining AA plasma 
homeostasis. We show that the aminoaciduria 
originates from an accumulation of AAs in the 
epithelial cells and we postulate that another 
basolateral uniporter, Lat4 (Slc43a2), 
compensates to a substantial extent for the lack 
of TAT1, in particular for driving the export 
function of the exchangers Lat2-4F2hc and 
y
+
Lat1-4F2hc in small intestine and kidney 
proximal tubule. 
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FIGURE LEGENDS 
 
FIGURE 1. TAT1 detection by immunofluorescence microscopy in sections of liver (A and B) and 
kidney (C and D). TAT1 is localized to the perivenous hepatocytes (A) and kidney proximal tubule 
cells (B) of wt tissues, whereas it is not detected in tat1
-/-
 tissues (B and D). V: central vein, G: 
glomerulus, S1: proximal convoluted tubule segment S1.  
 
FIGURE 2. Locomotor and coordination capability of tat1
-/-
 and wt littermates. Mice were tested with 
a RotaRod assay at accelerating and constant speed. Represented is the latency time before the first 
roll occurs (solid bars) and until first fall (open bars). Given are means ± SEM (n = 5). 
 
FIGURE 3. Free circulating amino acids in plasma: effect of high protein diet in wt mice (A) and 
altered amino acid profile in tat1
-/-
 (B). A: absolute concentrations of amino acids measured in plasma 
of wild type mice subjected to normal (20%) and high (40%) protein diet. * indicates P<0.05. B: 
plasma amino acid concentrations in tat1 knock out mice are shown relative to the values measured for 
their wild type littermates under the same diet. The horizontal line (y = 1) corresponds to the wt 
values. Represented are means ± SEM (n = 12). Groups were compared by one-way ANOVA, 
followed by Bonferroni posttest on selected pairs of columns. Values with letters are statistically 
different (P<0.05): 'a' and 'b' indicates difference of tat1
-/-
 versus wt under normal protein diet and high 
protein diet, respectively, 'c' indicates difference between normal protein and high protein diet in tat1
-/-
 
mice, ns all comparison are not significant. 
 
FIGURE 4. Concentrations of free amino acids in plasma and in cytosol of different organs. PL: 
plasma, Liv: liver, Sk. m: skeletal muscles (i.e. M. gastrocnemius), Kid: kidney. Represented means ± 
SEM (n = 6). ** indicates P<0.01 and *** P<0.001 by unpaired Student t-test. 
FIGURE 5. Urinary amino acid profiles: the high protein diet has no effect on wt mice (A) but 
enhances the aminoaciduria in tat1
-/-
 (B). A: total amino acids excreted in 24 hours by wild type mice 
subjected to normal (20%) and high (40%) protein diet. B: amino acids excreted in tat1 knock out 
mice are shown relative to the values measured for their wild type littermates under the same diet. The 
horizontal line (y = 1) corresponds to normalized wt values. The selectivity of known basolateral 
amino acid transporters measured in Xenopus laevis oocyte expression system is indicated below 
(References: [1] corresponds to (Ramadan, Camargo et al. 2007), [2] to (Meier, Ristic et al. 2002; 
Park, Kim et al. 2005) and [3] to (Bodoy, Martin et al. 2005)). +++ indicates high, ++ intermediate, + 
low and empty space no selectivity. Represented are means ± SEM (n = 12). Groups were compared 
by one-way ANOVA, followed by Bonferroni posttest on selected pairs of columns. Values with 
letters are statistically different (P<0.05): 'a' tat1
-/-
 versus wt in NPD, 'b' tat1
-/-
 versus wt in HPD, 'c' 
tat1
-/-
 NPD versus HPD, 'd' wt NPD versus HPD, 'ns' all comparison are not significant. 
 
FIGURE 6. 
123
I-2-I-L-Phe accumulation in kidney after i.v. injection. Fused micro-SPECT/CT and 
micro-CT coronal scans of a wt (A) and a tat1
-/-
 (B) mouse: the tat1
-/-
 animal presented a clear 
accumulation of the compound in both kidneys, whereas kidney accumulation was low in wt. C: 
quantification of the biodistribution in different organs after dissection. Represented is the percentage 
of injected activity of 
123
I-2-I-L-Phe in each tissue or organ per gram. Given are means ± SEM (n = 3). 
** indicates P<0.01 by unpaired Student t-test. 
FIGURE 7. Significant accumulation of L-Phe in intestinal everted gut sacs. Everted sacs of tat1
-/-
 and 
wt mouse small intestine were incubated at 37°C for 10 minutes in Krebs buffer containing 100 µM L-
Phe and 
3
H-L-Phe tracer. Radioactivity was counted inside of the sacs (serosa) and in the tissue 
(epithelial cells). Transport rates were calculated and normalized to weight of tissue. Represented are 
means ± SEM (n ≥ 8). * indicates P<0.05 by unpaired Student t-test. 
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 TABLE 1: Urinary and physiological parameters of males measured in metabolic cages for  
                     24 hours. 
Males 
Normal Protein Diet  
 (20% Casein) 
High Protein Diet  
(40% Casein) 
 wt tat1
-/-
 wt tat1
-/-
 
Urinary parameters:                   
pH 6.361 ± 0.03
 
6.46 ± 0.07 6.05 ± 0.06 c2 6.11 ± 0.02 d 
Creatinine (mg/24 hours) 0.174 ± 0.036 0.510 ± 0.088 1.150 ± 0.299 c 1.898 ± 0.316 d 
Creatinine (mg/dl) 40.2 ± 2.6 32.1 ± 2.9 22.8 ± 5.9 c 17.8 ± 0.9 
Urea (mg/dl)/crea (mg/dl) 166.7 ± 53.4 133.9 ± 23.4 332.1 ± 32.9 c 277.6 ± 29.5 d 
Na
+
 (mM)/crea (mg/dl) 8.58 ± 0.57 7.90 ± 0.49 9.45 ± 1.22 7.18 ± 0.98 
K
+
 (mM)/crea (mg/dl) 7.27 ± 0.26 6.38 ± 0.34 6.88 ± 0.71 5.38 ± 0.62 
Ca
2+
 (mM)/crea (mg/dl) 0.041 ± 0.001 0.048 ± 0.009 0.089 ± 0.008 c 0.078 ± 0.009 
Mg
2+
 (mM)/crea (mg/dl) 0.52 ± 0.06 0.36 ± 0.05 0.70 ± 0.13 0.59 ± 0.10 
Osmolality (mOsm/Kg H2O) 3148 ± 174 2260 ± 192 2660 ± 497 2072 ± 199 
                   
Urine volume (ml)/g BW 0.046 ± 0.005 0.086 ± 0.009 0.112 ± 0.019 c 0.164 ± 0.013 d 
Water intake (ml)/g BW 0.131 ± 0.014 0.244 ± 0.028 a 0.272 ± 0.023 c 0.362 ± 0.021 d 
Food intake (g)/g BW 0.142 ± 0.013 0.165 ± 0.010 0.144 ± 0.009 0.153 ± 0.009 
Feces (g)/g BW 0.021 ± 0.002 0.023 ± 0.001 0.020 ± 0.002 0.019 ± 0.002 
Body weight (g) 28.1 ± 1.0 25.7 ± 0.3 27.6 ± 0.8 26.2 ± 0.6 
Body weight (% change) 1.00 ± 0.00 1.00 ± 0.00 0.99 ± 0.01 1.02 ± 0.02 
 
1
Given are means ± SEM. (n = 6). 
2
Groups were compared by one-way ANOVA, followed by 
Bonferroni posttest on selected pairs of columns. Values with letters are statistically different 
(P<0.05): 'a' indicates that tat1
-/-
 and wt are significantly different under normal protein diet, 'c' that wt  
under normal and high protein diet are different and 'd' that tat1
-/-
  under normal versus high protein 
diet are different. No gender difference was observed. Female data can be found in supplementary 
Tab. 2. 
 
 
 
 
Figure 1 
 
 
  
11 
Original research article: “Aromatic amino acid transport and homeostasis”  57 
 
  
Figure 2 
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Figure 4 
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SUPPLEMENTARY MATERIAL 
 
Material and methods 
Growth Curve 
Weights of pups from tat1
+/-
 inter se breedings were recorded starting one day after birth. Animals 
were identified by marking the body with a Securiline alcohol-resistant lab marker (Precision 
Dynamics Corporation, USA). At day 6, fingers were clipped and animals genotyped by PCR. 
Morphological analysis of organs 
Tissues were harvested after heart perfusion with 50 ml 2.5% PFA in PBS, and 5 min incubation. 
After embedding in paraffin, organs were cut with a microtome (4 µm) and sections mounted and de-
paraffinized. Classical staining was performed by incubating 2 min in Mayer’s Hematoxylin solution 
(Sigma-Aldrich, Switzerland) and 1 min in Eosin Y solution alcoholic (Sigma-Aldrich, Switzerland). 
Oral glucose tolerance test 
After O/N starvation, 0.25 mg / µl D-Sucrose solution was injected i.p. in a dose of 3 g / kg body 
weight. Blood was sampled from the tail vein and measured with Accu-Check Aviva (Roche, 
Switzerland) at different time points.  
Oocytes uptakes 
Injection and uptake in oocytes was performed as described previously (Meier, Ristic et al. 2002; 
Ramadan, Camargo et al. 2006). After injection of 10 ng of cRNA, oocytes were incubated for 18 
hours (lat2-4F2hc) or 3 days (tat1 and lat4) at 16°C in ND96 solution. Uptakes of 100 µM L-Phe were 
performed for 3 min. The 2-I-L-Phe used was kindly provided by the In vivo Cellular and Molecular 
Imaging Center Brussels. Depicted values were corrected by subtraction of the uptake of non-injected 
oocytes.  
Content of distal small intestine 
Experiment was performed as in Singer et al., (in revision). Animals were starved for 12 hours before 
the experiment to empty the intestine and reduce variation. A 10 ul / g bolus of PBS solution 
supplemented with amino acids (each AA was set at a final concentration that reflected 10x the plasma 
15 
Original research article: “Aromatic amino acid transport and homeostasis”  61 
 
  
values depicted in Fig. 3A) was given by oral gavage. Animals were kept in their own cages and 
sacrificed after 1h. The small intestine was carefully removed and the last 10 cm before the caecum 
cut at both ends. The content of this segment was collected by flushing with 1 ml of PBS and the 
amino acid concentration of this solution then measured by UPLC, as described before.  
 
Suppl. Tab. 1a:    mRNA abundance of several amino acid transporters in different tissue lysates  
                               relative to HPRT.  
 
           Liver                                           Small intestine           Kidney 
           Duodenum          Jejunum        Ileum       
                             
tat1 
wt 3.3 ± 0.7
1 
  10.5 ± 1.2   22.4 ±   2.9   10.3 ± 1.6   1.4 ± 0.2   
tat1
-/-
 0.4 ± 0.1 **
2 
1.4 ± 0.3 *** 4.9 ±   0.7 *** 2.3 ± 0.6 *** 0.1 ± 0.01 *** 
lat2 
wt 0.1 ± 0.02  7.7 ± 1.1  105.1 ± 21.5   17.5 ± 4.9  2.2 ± 0.5   
tat1
-/-
 0.1 ± 0.03   7.1 ± 1.1   72.4 ±   9.7   16.1 ± 3.2   2.0 ± 0.2 
  
lat4 
wt 0.9 ± 0.2   33.2 ± 2.4   68.5 ± 10.6   44.9 ± 3.4   3.8 ± 0.2   
tat1
-/-
 0.3 ± 0.1 ** 22.9 ± 2.8 * 61.0 ±   2.0   48.2 ± 7.5   4.2 ± 0.3 
  
4F2hc 
wt 4.4 ± 0.7  49.2 ± 3.8  125.5 ± 17.3   48.7 ± 4.5  12.7 ± 2.1   
tat1
-/-
 4.1 ± 0.7   35.2 ± 4.4 * 136.3 ± 11.5   65.0 ± 17.5   11.9 ± 1.6 
  
B
0
AT1 
wt      21.8 ± 3.8   22.6 ±   3.7   35.5 ± 3.5   3.1 ± 0.5   
tat1
-/-
      17.4 ± 2.5   29.5 ±   4.3   31.4 ± 1.7   4.2 ± 0.4   
 
                      1
means ± SEM. (n ≥ 10). 
2 
* indicates P<0.05, ** P<0.01 and *** P<0.001 by unpaired Student t-test.  
 
 
Suppl. Tab. 1b:   mRNA abundance of several amino acid transporters in muscles and fat 
                             relative to HPRT. 
  
Muscles Fat   
  Gastrocnemius Soleus Heart       
                          
tat1 
wt 3.41 ± 0.81
1 
  1.00 ± 0.23   0.58 ± 0.25   0.31 ± 0.14   
tat1
-/-
 0.76 ± 0.21 *
2 
0.55 ± 0.20   0.19 ± 0.10   0.70 ± 0.38 
  
lat2 
wt 0.18 ± 0.05   0.03 ± 0.01                
tat1
-/-
 0.30 ± 0.05   0.04 ± 0.02                   
lat4 
wt 0.30 ± 0.06   1.23 ± 0.43   0.27 ± 0.04   0.24 ± 0.02   
tat1
-/-
 0.46 ± 0.08   1.03 ± 0.10   0.46 ± 0.25   0.24 ± 0.01   
4F2hc wt 1.73 ± 0.33   1.55 ± 0.68   2.84 ± 0.08   2.61 ± 1.40   
tat1
-/-
 1.63 ± 0.27   1.79 ± 0.69   2.56 ± 0.22   6.78 ± 1.09   
 
                        1
 means ± SEM. (n = 10-15). 
2
 means ± SEM. * indicates a P<0.05. 
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Suppl. Fig. 1: Growth after birth. Represented means ± SEM. (n = 4). 
 
 
 
 
 
 
 
Suppl. Fig. 2: Organs have normal morphology: hematoxylin and eosin staining on 4 µm 
paraffin sections. 
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Suppl. Fig. 3: Oral glucose tolerance test. Represented means ± SEM. (n = 4). 
 
Tab. 2:    Urinary and physiological parameters of females measured in metabolic cages for 
                24 hours. 
Females 
Normal Protein Diet   
(20% Casein) 
High Protein Diet  
(40% Casein) 
 wt tat1
-/-
 wt tat1
-/-
 
Urinary parameters:                   
pH 6.31
1 ± 0.06 6.36 ± 0.10 5.92 ± 0.07 c2 5.97 ± 0.04 d 
Creatinine (mg/24 hours) 0.059 ± 0.047 0.199 ± 0.043 0.394 ± 0.116 1.045 ± 0.165 bd 
Creatinine (mg/dl) 42.9 ± 10.6 23.1 ± 3.7 22.4 ± 3.2 18.1 ± 1.9 
Urea (mg/dl)/crea (mg/dl) 247.0 ± 25.6 272.9 ± 22.2 561.1 ± 73.9 c 354.0 ± 69.1 
Na
+
 (mM)/crea (mg/dl) 12.39 ± 1.95 11.46 ± 0.99 11.02 ± 0.79 9.05 ± 0.66 
K
+
 (mM)/crea (mg/dl) 8.72 ± 1.14 9.15 ± 0.64 8.68 ± 0.57 6.60 ± 0.65 
Ca
2+
 (mM)/crea (mg/dl) 0.089 ± 0.017 0.106 ± 0.019 0.184 ± 0.045 0.130 ± 0.016 
Mg
2+
 (mM)/crea (mg/dl) 0.78 ± 0.18 0.76 ± 0.15 1.08 ± 0.24 0.98 ± 0.14 
Osmolality (mOsm/Kg H2O) 4136 ± 990 2342 ± 348 3652 ± 589 2257 ± 204 
                   
Urine volume (ml)/g BW 0.023 ± 0.011 0.070 ± 0.008 a 0.086 ± 0.016 c 0.156 ± 0.013 bd 
Water intake (ml)/g BW 0.277 ± 0.041 0.304 ± 0.022 0.353 ± 0.028 0.402 ± 0.020 
Food intake (g)/g BW 0.185 ± 0.005 0.207 ± 0.010 0.186 ± 0.005 0.187 ± 0.008 
Feces (g)/g BW 0.028 ± 0.005 0.029 ± 0.002 0.025 ± 0.002 0.026 ± 0.003 
Body weight (g) 20.9 ± 0.6 19.7 ± 0.6 21.2 ± 0.5 20.5 ± 0.6 
Body weight (% change) 1.00 ± 0.00 1.00 ± 0.00 1.02 ± 0.02 1.04 ± 0.01 
 
1
Given are means ± SEM. (n = 6). 
2
Groups were compared by one-way ANOVA, followed by 
Bonferroni posttest on selected pairs of columns. Values with letters are statistically different 
(P<0.05): 'a' indicates that tat1
-/-
 versus wt are statistically different under normal protein diet, 'b' that 
tat1
-/-
 versus wt are different under high protein diet, 'c' and 'd' that there is a significant difference 
between normal and high protein diet in wt and tat1
-/-
, respectively.  
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Suppl. Fig. 4: L-Phe uptake is competed by 2-I-L-Phe. Oocytes were injected either with tat1, lat2-
4F2hc or lat4 cRNAs and uptakes of 100 µM L-Phe were performed without competition (control, 
white bars), or in the presence of 1 mM 2-I-L-Phe (grey bars) and 5 mM 2-I-L-Phe (black bars). The 
residual uptake fractions are indicated above the bars as percent of control. The bars represent means ± 
SEM. (n = 8-10). * indicates a P<0.05, ** a P<0.01 and *** a P<0.001 by unpaired Student t-test. 
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Suppl. Fig. 5: Amino acids reaching the distal part of the small intestine. 1 hour after an oral load 
of amino acids the animals were sacrificed and the content of the last 10 cm of small intestine (ileum) 
collected. The quantification did not reveal a statistical difference between tat1
-/-
 and wt mice. 
Represented are means ± SEM (n = 4). 
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5.3. Addendum 
 
 
5.3.1 Low protein diet study 
In concomitance with the high protein diet (PD) treatment, whose results are presented in the previous 
section, a low protein challenge was similarly performed. For this, an isocaloric casein free diet was 
provided for 8 consecutive days to the mice either at the end or at the beginning of the challenge. 
Under this condition the mice immediately displayed a considerable loss of body weight, which 
progressively continued (Fig. 15). Nevertheless, the animals presented a normal behavior as judged by 
the absence of signs of apathy, pain, weakness and diarrhea. Furthermore, the animals were able to 
regain the majority of their weight in the 48 hours consecutive to the normal PD switch, however 
without being able to fully recover (Fig.15B). The body weight progression along the whole dietary 
challenge was identical in wt and tat1
-/-
.  
 
The amino acid analysis in plasma of animals treated with the casein free diet revealed higher 
concentrations of Ala and Gln, which were shown to be hallmarks for low protein diet as a 
consequence of elevated muscle protein catabolism (Peters and Harper 1985; Moundras, Remesy et al. 
1993) (Fig. 16A). Free plasma Arg was also slightly increased, probably as a consequence of 
diminished urea cycle. Indeed, when the urinary urea was measured with the diacetyl monoxyme 
method (Wybenga, Di Giorgio et al. 1971), all samples lied below the detection limit of the assay, 
which indicates an extremely low abundance (not shown). Many other essential amino acids were less 
concentrated, among those also the aromatic and the branched chain ones, as a consequence of the 
abolished dietary intake. In the urine after low PD, if compared to normal PD, a drastic decrease in all 
amino acid concentration was observed (Fig. 16B). The plasma of tat1
-/-
 presented the same relative 
trend displayed under normal PD, although in a reduced smaller extend due to the dietary  amino  acid  
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deprivation: elevated aromatic amino acid in the circulation. Under low PD no difference between wt 
and tat1
-/-
 was observed in the urinary content, not surprisingly in the light of the general extremely 
low values recorded. In conclusion, the steep decrease in body weight and the major differences 
observed in urinary amino acids indicates that the protein free diet is a too harsh intervention and that 
a 5-7% casein diet would be more adequate. Nevertheless, tat1
-/-
 mice reacted to the treatment in a 
similar way as wt and seemed therefore not to be disadvantaged by their mutation. 
 
 
Fig. 15: Progression of body weight during the dietary challenge. Mice were divided into two 
groups: A. the first received sequentially the high (40% casein), normal (20%) and low (0%) protein 
diet (PD) and B. the second group received the diets in the opposite order. Represented means ± SEM 
(n = 6).  
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Fig. 16: Amino acid profiles showed hallmarks of low PD in plasma and a much less presence in 
the urine. A. plasma amino acid profiles showed increased Ala and Glu and decreased BCAA similar 
to other studies (Peters and Harper 1985; Moundras, Remesy et al. 1993). Although in a lesser extent, 
tat1
-/-
 displayed the same relative trend observed under normal PD. B. Urinary amino acid excreted in 
24 hours showed a drastic decrease under low PD in both, wt and tat1
-/-
. 
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5.3.2 Validation of the everted gut sac technique 
An improved system of the everted gut sac technique for rats has been reviewed in 1998 (Lloyd and 
Whelan 1969; Barthe, Woodley et al. 1998). With the mediation of Moritz Jüttner (University Hospital 
Zürich), the protocol used here has been further optimized for the application in mice, based on the 
experience of the Daniel’s lab (Technische Universität München) (Stein, Daniel et al. 1994; Nassl, 
Rubio-Aliaga et al. 2011). The description of the procedure can be found in the material and methods 
section (4.1.10) and in the tat1 manuscript (5.2). Briefly, 1.5 cm long pieces of small intestine 
(duodenum and jejunum) were everted so that the mucosa, which normally faces the lumen, was 
turned inside out (Fig. 17A). Thus, the inside of the newly formed sac reflected the extracellular space 
in the body and has been named serosa, referring to the last anatomical structure that can be found (see 
3.2.2). The bags were ligated at both ends and a KREBS buffer was introduced in the inside with a 
syringe at one end. The exact volume introduced was calculated from the weight difference of the 
syringe. The bag was incubated in a 37°C pre-warmed oxygenated KREBS buffer supplemented with 
the tested substrates and their tracers (Fig. 17B). At the end of the incubation, the sacs were washed 
with 30 ml ice cold sodium deprived KREBS buffer, cut open and the sac contents were collected. The 
tissues were dried at 55° C over night, weighted and consecutively lysed with a dedicated kit 
(Solvable, Perkin Elmer). Since the intestine has been everted and since the substrates for uptake has 
been added at the mucosal part (Fig. 17A and B), the concentration inside of the bag indicates the sum 
of transepithelial (active) and paracellular (passive) transports. Therefore, in order to discriminate 
between both components, a co-incubation with 
14
C-mannitol, which only diffuses paracellularly, was 
performed. The exclusion criterion for sacs presenting a serosal mannitol content higher than 5% of 
the total has been applied. Similarly, a threshold of 1% has been applied for the tissues.  
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Before performing the experiment presented in the tat1 manuscript (see 5.2), several trial aiming at 
controlling the consistency of the new system were performed. First, the transport rate at 4°C was 
significantly diminished (Fig. 17C), which agrees to thermodynamic laws and to experiments in X. 
laevis heterologous expression system. Therefore, the majority of the measured transport was active 
and not paracellular. Second, compared to wt the transport rates of Leu were significantly decreased in 
ace2
-/y
 (Fig. 17D), which is in agreement with the data published by Camargo, Singer and co-workers 
obtained with the intestinal ring technique where the same differences were observed (7 nmol/mg in 
wt; 2 nmol/mg in ace2
-/y
) (Camargo, Singer et al. 2009). Last, time course plots showed a progressive 
increase in the transport rates and an accumulation of Phe in the serosa, which however stopped 
around 100 µM (Fig. 18). 
 
 
Fig. 17: the everted gut sacs technique  and controls. A: schematic view of the epithelium in the 
everted gut sac assay. The substrates are applied form the outside of the bag, which after evertion 
corresponds to the mucosa. The buffer alone is applied in the serosa side (inside of the sac). Serosa 
and tissue radioactivity was measured with scintillation reaction. B: a representative picture of the 
experiment. Arrows indicate where the different buffers were applied. C: the transport was almost 
stopped when sacs were incubated in ice cold buffer. Thus, the majority of the transport measured at 
37°C is active (transepithelial). D: ace2
-/y
 tissues showed a reduced transport of Leu. This result is 
comparable to the one obtained with the intestinal ring technique (Camargo, Singer et al. 2009). 
Represented means ± SEM (n = 3 - 5). * indicates P<0.05 and ** P<0.01 by unpaired Student t-test. 
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Fig. 18: Time course of transport rates and concentrations measured with everted gut sacs. A: 
time course in wt from mucosa to tissue (red) and mucosa to serosa (green). B: Absolute 
concentrations measured within the serosa at different time points. Represented means ± SEM    
(n = 5 - 10). 
 
 
5.3.3 Everted gut sacs experiments with tat1
-/-
 
tat1
-/-
 gut functionality was tested with the everted gut sacs technique to assess amino acids transport 
rates. The results for Phe are reported in the manuscript (see 5.2). The measured significant 
accumulation in the tat1
-/-
 tissues parallels the 2-I-L-Phe accumulation in kidney epithelial cells 
observed with the microSPECT technique. However, due to the high variance, which is probably 
secondary to the heterogeneous expression of the transporters along the small intestine, and due to an 
effective small difference in transport, the transepithelial transport was not different (serosa). In the 
kidney this rate is likely to be impaired, as suggested by the aminoaciduria. Tyr has also been tested, 
since in contrast to Phe, Tyr is not well transported by lat4 (Bodoy, Martin et al. 2005). Surprisingly, 
incubations of 10 and 60 min did not display a difference between wt and tat1
-/-
 (Fig. 19). The 
measured rates were similar to the ones of Phe, with the exception of the 60 min serosa, which tended 
to reach much higher concentrations. More time points and probably higher concentrations should be 
considered in further analysis. 
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Using the X. laevis expression system, it was shown that Gln is released from oocytes expressing both 
tat1 and lat2, but not from those expressing lat2 solely (Ramadan, Camargo et al. 2007). To mimic 
that effect, Gln transport in wt and tat1
-/-
 sacs was studied in presence and absence of Phe in mucosa or 
serosa (Fig. 20A). The concentrations were chosen in order to exceed the transport affinities (Meier, 
Ristic et al. 2002) in order to obtain an efficient apical transport and to saturate lat2-4F2hc exchanger. 
Indeed when a high concentration of Phe was applied in the serosa, a minor increase in Gln transport 
was observed in the wt. In contrast, the application of 100 µM Phe in mucosa did not reveal any trend 
of higher transport. In the same situation however, a significantly higher amount of Gln was 
transported in tat1
-/-
. This unexpected trend was not reproduced by the transport of Ser in the presence 
of Phe (Fig. 20B) but only when Phe was substituted with Tyr (Fig. 20C). Currently there is no 
explanation for the unexpectedly high transport in the tat1
-/-
. Nevertheless, since the measurement 
relies solely on the detection of the tritium in the solutions, the metabolism in the enteric cells must be 
taken into account. Indeed several non-essential amino acids, including Gln, have been shown to be 
extensively oxidized by the epithelial cells of the small intestine (Stoll, Henry et al. 1998; Wu 1998; 
Wu 2009). In contrast, Tyr should not be metabolized, as shown from first pass intestinal studies 
(Stoll, Henry et al. 1998; Wu 1998), whereas Phe is catabolized in a lesser extended (Biolo, Tessari et 
al. 1992; Hoerr, Matthews et al. 1993). In our assay the tracers could therefore have been degraded 
and the tritium transferred to water, which could consequently leave the cell and diffuse paracellularly. 
A validation of the transstimulation assay should therefore be achieved by measuring the effective 
concentration of the substrate by HPLC or by using 2-I-L-Phe, which would not be further 
metabolized. Furthermore, the turnover of the epithelial proteins should be investigated, to rule out the 
possibility of a different metabolism in tat1
-/-
, which would cause the misinterpretations. 
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Fig. 19: wt and tat1
-/-
 showed no difference in Tyr transport. Tyr transport displays similar rates 
than Phe upon 10 min incubation (A) and higher serosa accumulation after 60 min (B). wt and tat1
-/-
 
displayed the same rates overall. Represented means ± SEM (n = 5 – 6). 
 
 
Fig. 20: Transstimulation of Gln and Ser transport by application of Phe and Tyr in mucosa or 
serosa. A: a small increase in serosal Gln transport was observed after application of Phe in serosa, 
but not in mucosa. tat1
-/-
 tissues presented an unexpectedly high transport rate. B: no effect has been 
observed in the transport of Ser. C: after substitution of Phe with Tyr an effect in Ser transport was 
observed similarly to Gln. Groups were compared by one-way ANOVA, followed by Bonferroni post-
test on selected pairs of columns. Values with letters are statistically different (P<0.05). Represented 
means ± SEM (n = 4 – 12). 
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5.3.4 Measurement of the glomerular filtration rate 
It is well established that high plasma amino acids and postprandial state alters renal hemodynamics 
and lead to hyperfiltration (Castellino, Coda et al. 1986; Premen 1988; Castellino, Levin et al. 1990). 
It has been further demonstrated that different protein contents in the diet exert a similar effect 
(Sallstrom, Carlstrom et al. 2010). Since tat1
-/-
 displayed high circulating aromatic amino acids (see 
manuscripts in 5.2 section), it is well conceivable that tat1
-/-
 presents a higher gromerular filtration rate 
(GFR). In the assessment of the theoretical fractional excretion of amino acids in tat1
-/-
, an invariable 
GFR was used as reference (Qi, Whitt et al. 2004). The data presented in the manuscript were derived 
by calculating the total amino acids excreted in 24 hours by knowing the total urinary volume. A 
common praxis in humans is to normalize the measured amino acid concentrations to the urinary 
creatinine. Although this is a well established procedure, the accuracy of such method in mice has 
been recently discussed: creatinine has been shown to be secreted along the nephron and therefore 
causes an overestimation of the real GFR; furthermore creatinine is proportional to the muscle mass 
and thus not homogeneous (Breyer and Qi 2010; Eisner, Faulhaber-Walter et al. 2010). Therefore an 
attempt to measure the real GFR by mean of inulin clearance has been made following a recently 
published protocol ((Sallstrom, Carlstrom et al. 2010) and material and methods section 4.1.8). The 
measurement were performed in 8 animals kept under normal protein diet (NPD, 20% casein) for 
baseline and under high (HPD, 40% casein) or low (LPD, 0% casein) protein diet for 8 days. The 
results indicated a clear decrease in the GFR in mice kept under the LPD, regardless of their genotype 
(Fig. 21A). In contrast under HPD there was an increase in GFR for the wt, but not for the tat1
-/-
. This 
last observation contrasts with the initial hypothesis that in tat1
-/-
 higher plasma amino acids would 
higher the GFR, however the high variability of the measured points suggest for caution in the 
interpretation. In fact, unsuccessful i.v. injections leaded to the exclusion of several animals (e.g. 
representative in Fig.21B and C): the wrong compartmental distribution of the bolus in the 
extracellular fluid caused an initial increase instead of a steep decrease in plasma activity. Furthermore 
the restrain of the animal caused variable stress, which in turn caused further difference in 
hemodynamics.  
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In conclusion, the use of the 24 hour volume to calculate the AA excreted amount appeared to be a 
more adequate system. However, if the unexpectedly low GFR observed in tat1
-/-
 under HPD would be 
taken in account, it would not weaken the results but rather increase the magnitude of the presented 
phenotype in the manuscript (see 5.2).  
 
 
 
Fig. 21: Glomerular filtration rates (GFR) varies upon different protein loads in the diet. A: 
variation in the GFR measured after 8 days of low PD (0% casein) or high PD (40% casein). 
Represented means ± SEM (n = 6 – 8). B: example of a successful measurement in an animal, where a 
2 exponential fit was possible. C: example of a bad quality measurement, discarded by the exclusion 
criteria: although fitting of the low PD data (green triangles) could be improved by the exclusion of 
the first 2 time points, the normal PD data (blue triangles) were abnormally low, probably due to a 
wrong i.v. injection. 
 6. lat4 Mouse Model 77 
 
 
  
 
 
6. lat4 Mouse Model 
 
6.1 Introduction 
 
Immediately after the first inter se cross of tat1
+/- 
animals, it appeared that the impact of tat1 absence 
was not causing lethality. Furthermore, the analysis of tat1
-/-
 urine showed an almost normal fractional 
reabsorption of all amino acids (Verrey, Singer et al. 2009). Thus, taken together all the results of the 
tat1
-/- 
characterization discussed in the first part of this work (see section 5), suggest that one or more 
compensating mechanisms must take place to rescue the tat1
-/- 
mice. As explained more extensively in 
the discussion of the manuscript (see 5.2), no upregulation of known amino acid transporters has been 
found in tat1
-/-
. Therefore, one or more transporters normally present in the basolateral membrane 
should cover the compensatory role. We proposed that lat4 (SLC43A2) could be involved in this 
action for several reasons. Firstly, Lat4 functions as facilitated diffusion transport for essential amino 
acids in a Na
+
 independent manner (Bodoy, Martin et al. 2005), which exactly reflects the properties 
of tat1. Secondly, lat4 present a narrow selectivity for BCAA, L-Met and L-Phe, thus sharing at least 
one substrate with tat1. Furthermore, X. laevis oocytes expressing lat4 also showed minor transport of 
L-Trp and L-Tyr in both, uptake and competition assays (Bodoy, Martin et al. 2005). Third, lat4 
mRNA has been shown to be expressed in mouse small intestine and in kidney, but not in the liver 
(Bodoy, Martin et al. 2005). A last argument was provided by the substitution assay performed in the 
X. laevis oocytes expression system, where lat4 could functionally cooperate with lat2-4F2hc in a way 
similar to tat1 (Ramadan, Camargo et al. 2007).  
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As already discussed in the introductory part of this work, lat4 belongs to the slc43 gene family, which 
comprises 2 other members: lat3 (SLC43A1) and eeg1 (SLC43A3) (http://www.bioparadigms.org/slc, 
(Hediger, Romero et al. 2004; Broer 2008)). eegl1 is an orphan transporter mostly expressed in fetus 
starting at embryonic day 7 but not during adulthood. Furthermore, eegl1 did not show so far amino 
acid transport properties in the oocyte expression system (Stuart, Pavlova et al. 2001), in contrast to 
lat3, which transported several neutral amino acids. Nevertheless, lat3 mRNA expression was 
confined to pancreas, skeletal muscles and liver (Babu, Kanai et al. 2003), and thus excluding its 
involvement in intestine and kidney. So far, the only other known amino acid uniporters are CATs 
(SLC7 family) (Verrey, Closs et al. 2004; Broer 2008; Verrey, Singer et al. 2009), that belong to the y
+
 
system because they transport cationic amino acids and that would thus not provide any neutral 
substrates to lat2-4F2. 
 
In the light of all this evidences, we ordered a lat4 knock out mouse (lat4
-/-
) from the Phenogenomic 
center of Toronto (http://www.phenogenomics.ca/). ES cell line used to generate the knock out 
contained a gene trap allele with UPA gene trap vector (Shigeoka, Kawaichi et al. 2005) inserted in the 
6
th
 intron of lat4 gene. This resulted in the truncation of the Lat4 protein. For more details, please 
consult the material and methods section (4.1.2). 
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6.2 Results 
 
6.2.1 First crossings of lat4 animals 
The first crossings of animals from Toronto delivered in a mixed B6/ICR/129 background generated 
89 pups, among which the majority of lat4
-/-
 died prematurely. In fact, only one female survived and 
reached adulthood. The detailed list is reported in the following table: 
Breeding pair   Number of pups   
Mother Father 
 
at Birth at weaning Died day of death 
first round of crossing 01.2010         
lat4
+/-
 lat4
+/-
 
A 8 (1k.o.) 7 1 8d 
B 14 12 2 5d/5d 
C 10 8 2 8d/8d 
D no pups       
E 8 5 3 8d/8d/8d 
F 6 5 1 8d 
G 8 5 3 8d/8d/8d 
H 9 9     
I no pups       
K 5 3 2 8d/8d 
  
 
TOT: 68 54 14   
second round of crossing 
07.2010         
lat4
+/-
 lat4
+/-
 
A 6 5 1 8d (k.o.) 
B 10 7 3 6d/12d/12d 
C 3 3 0   
D 9 8 1 9d (k.o.) 
E 6 4 2 3d/3d 
F 7 7 0   
G 7 7 0   
H 9 0 9 2d all 
I 3 2 1 4d 
K 6 6 0   
L 8 8 0   
M 8 (1k.o.) 8 (1k.o.) 0   
N 7 6 1 4d 
  
 
TOT: 89 71 18   
first roud of crossing 01.2011         
lat4
-/-
 lat4
+/-
 
A 11 (3k.o.) 10 (2k.o.) 1 4d (k.o.) 
B 0 0 0   
    TOT: 11 10 1   
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6.2.2 Preliminary analysis of a survival family 
As visible in table shown in section 6.2.1, the first generation of mice with mixed B6/ICR/129 
background gave birth to one viable lat4
-/-
 female (breeding pair M). The female presented no obvious 
phenotype and generated additional 3 lat4
-/-
, among which 2 reached adulthood. Similar to their 
mother, the two survivors showed no obvious phenotype and, when paired with lat4
+/-
 partners in the 
attempt to further generate knock outs, they both repeatedly failed. In particular, the offspring male 
failed to fecundate the respective lat4
+/-
 partners, which did not show signs of pregnancy. The female 
never got pregnant either.  
One lat4
-/-
 animal was put into metabolic cage together with other lat4
+/- 
and wt. The animals were 
sacrificed and organs prepared for histological and morphological analysis. The 7 month old lat4
-/-
 
male was slightly underweight (22.7 g) compared to the mean weight of its littermates (33.5 g). The 
lat4
-/- 
presented a left renal hypertrophy (enlarged kidney) and a right renal atrophy (small kidney). 
The histological analysis of both kidneys on hematoxylin eosin stained sections showed a higher 
number of fibroblasts and mononuclear cells in the mesenchyme of the left kidney. Extensive fibrosis 
(collagenous fiber-like staining) and morphological similarities with a polycystic kidney were also 
observed. The right kidney showed less cell presence in the mesenchyme but higher level of fibrosis 
(Fig. 22). The other lat4
-/-
 male showed less fibroblasts or mononuclear cells and no signs of kidney 
hypertrophy or atrophy.  
In the overall, the kidney of lat4
+/-
 showed no macroscopical difference. However, their section 
showed all over particular signs of local degeneration of the tubuli (e.g. arrows Fig. 23). Interestingly, 
this kind of microcyst formations were also reported in another haploinsufficient mouse, pdk1
+/-
, 
which has been shown to be involved in the autosomal dominant polycystic kidney disease (ADPKD) 
(Bastos, Piontek et al. 2009). Nevertheless this observation must be confirmed by more detailed 
electron microscope images and a larger number of animals should be examined. 
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The testis the lat4
-/-
 male showed less layers of spermatogenic epithelium in seminiferous tubule and 
fewer spermatogonium, primary and secondary spermatocytes have been found (Fig. 24). The 
spermatoid found in seminiferous tubule were also less numerous in lat4
-/-
. Both, lat4
-/-
 and lat4
+/-
 
presented no difference in liver, muscle, lung or heart if compared to wt. Similarly, there was no 
obvious bone marrow functional difference between groups, as judged by the ratio of cells with 
nucleus and those without nucleus in giemsa stained smeared slides. 
At the age of 7 month, before sacrifice and organ collection, the lat4
-/-
 male was housed in metabolic 
cages for urine collection. The total blood was also collected and the plasma analyzed for its amino 
acid content. The analysis of plasma showed minor differences in amino acid values between lat4
-/-
 
and wt: Pro and Asp were 30% less concentrated in the lat4
-/- 
(Fig. 25A), whereas all other amino acids 
were only slightly less concentrated, with the exception of Trp, which was 20% more concentrated. 
The 24 hours urine analysis showed a peculiar pattern of amino acid loss: Ala, Val and Asp were more 
than 5 fold concentrated; Gly, Leu, Thr, Pro, Asn, Gln, Arg, His and Glu ranged between 2 and 5 fold 
more (Fig. 25B). Interestingly Ile and Met, two good substrates of lat4, were not significantly 
different. Surprisingly, the more prominent effect observed was the one of Asp, which is not a 
substrate of Lat4 (Bodoy, Martin et al. 2005). Phe was not detected in the urine of lat4
-/-
. These data 
must be taken with caution, because the absence of further lat4
-/- 
experimental mice limited the number 
to one single case. The comparison between lat4
+/-
 and wt did not reveal differences (Fig. 25). 
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Fig. 22: Kidney sections stained with hematoxylin and eosin presented signs of fibroblast and 
mononuclear cells infiltration in the lat4
-/-
 mesenchyma. Upper raw 4x magnification, below 20x. 
 
 
Fig. 23: Kidney section of lat4
+/-
 showed microcyst formations, similarly to pdk1
+/-
 phenotype 
(Bastos, Piontek et al. 2009). Hematoxylin and eosin kidney sections were overexposed. Microcysts 
were found all over the specimen. Arrows indicates two examples of microcysts. 20x magnification. 
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Fig. 24: sections of testis stained with hematoxylin and eosin presented less spermatocytes in the 
lat4
-/-
. 20x magnification. 
 
 
Fig. 25: The lat4
-/-
 showed normal plasma values but higher urinary amino acids. A: plasma 
amino acid concentrations did not reveal significant differences between groups. Interestingly, Pro and 
Asp are less present in the knock out. B: many urinary amino acids normalized to the creatinine 
content showed much higher levels in the lat4
-/-
. Represented mean ± SEM. 
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6.2.3 Preliminary analysis of animals backcrossed in C57BL/6 background 
In parallel to the analysis of the B6/ICR/129 mixed lat4
-/-
 mice, a backcross into the conventional 
C57BL/6 strain was set up. Once the 3
rd
 backcross generation was reached, lat4
+/-
 inter se crossings 
were set to further generate experimental animals. In the light of the small number of lat4
-/-
 found in 
the first litters, an even more careful monitoring of the litter size and pup weight was performed. At 
birth, the nest presented a normal size (average of 8 animals per litter). Despite differences in each 
litter, the total number of animals per genotype was not significantly different than the ones obtained 
with a mendelian’s distribution. The litters were distributed as follows: 
 
Breeding pair   Number of pups 
Mother Father 
 
at Birth lat4
-/-
 wt lat4
+/-
 
  
  
        
lat4
+/-
 lat4
+/-
 
A 5 1 0 4 
A 9 1 7 1 
A 8 2 0 6 
B 7 2 4 1 
B 7 2 2 3 
B 8 2 0 6 
B 10 3 3 4 
  
 
TOT: 54 13 16 25 
  
 
Percentage: 100% 24% 30% 46% 
    Expected: 100% 25% 25% 50% 
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At birth, all pups presented a normal color of the skin and the lat4
-/-
 mice were undistinguishable from 
their littermates: the lat4
-/-
 differed less than 15% in body size (average thorax length of 2.1 for lat4
-/- 
versus 2.4 of lat4
+/-
; Fig. 26). The milk spot, a white area in correspondence of the stomach caused by 
the presence of milk, was well visible 24 hours after birth and remained within the next days in all 
pups, suggesting that the suckling behavior was normal and all animals had normal access to food. 24 
hours after birth the animals started to differ in their body weight and continued to have a smaller net 
weight gain in the following 24 hours (Fig. 27). Despite the fact that the percentage weight gain was 
only of 10% for the lat4
-/-
 in contrast to the 25% of wt and lat
+/-
, it stayed positive indicating that the 
mice did not lose weight. 48 hours after birth, the animals were sacrificed and their plasma and organs 
collected.  
 
 
 
Fig. 26: the size of lat4
-/-
 pups was less than 15% smaller than lat4
+/-
 littermates and showed no 
other distinguishable marks. Pictures of littermates were taken 24 and 48 hours after birth. The 
thorax length was calculated as the measure between the basis of the neck and the basis of the tail: 
lat4
-/-
 measured on average 2.1 cm whereas lat4
+/-
 2.4 cm. 
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Fig. 27: 24 hours after birth, lat4
-/-
 weighted less and continued to grow less within the following 
24 hours. Left: average body weight measured 24 hours after birth in the same litter. Right: average 
net weight gain of the same animals between 24 to 48 hours after birth. Represented means ± SEM (n 
= 3 to 6). ** indicates P<0.01, *** P<0.001 and by unpaired Student t-test.  
 
  
 6. lat4 Mouse Model 87 
 
 
  
 
6.2.4 Lat4 localization 
Bodoy and co-workers concluded based on “in situ hybridization” that lat4 mRNA is presumably 
expressed in the epithelial cells of the distal tubule and the collecting duct of the kidney as well as in 
the intestine, being mainly present in the cells of the crypts (Bodoy, Martin et al. 2005). The 
inspection of the proposed images showed indeed strong signals in distal tubular segments and a 
fainter staining in proximal tubule cells. With regard to the intestine, a strong signal was present in the 
crypts and a faint signal was also visible in the enterocytes of the villi. The first approach was to 
micro-dissect the kidney into its different component (See introduction 3.2.3), extract mRNA from 
proximal convoluted (PCT) and proximal straight tubule (PST) and perform quantitative PCR analysis 
of different transporters. The results showed that lat4 was expressed in both segments, with a higher 
expression in the PST, where tat1, lat2 and 4F2hc were no longer expressed (Fig. 28). Here XT2 and 
B
0
AT1 were used as markers for the proper selection of the segments: XT2, which was recently 
renamed B
0
AT3, is expressed in the late proximal straight tubule (PST); B
0
AT1 localizes to the early 
proximal convoluted tubule (PCT) (Romeo, Dave et al. 2006; Singer, Camargo et al. 2009).  
 
 
Fig. 28: microdissection of kidney revealed that lat4 is expressed in PCT and PST, whereas tat1, 
lat2 and 4F2hc only in the PCT. B
0
AT1 and XT2 are controls for PCT and PST respectively. (n = 1). 
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7. Discussion and Outlook 
 
7.1 Discussion 
 
7.1.1 Advances in the characterization of the AA transporters 
In the past decades, very large progress in the characterization of AA transporters has been made. For 
more details see the introductory part (3.2). Briefly, the first discoveries allowed the classification of 
transport systems based on their physicochemical, stereospecific, inhibitors and selectivity properties 
(Stevens, Ross et al. 1982; Verrey, Singer et al. 2009). A second big progress in the characterization of 
AA transporters was done with the molecular identification, DNA cloning and cellular expression that 
allowed the biochemical and more precise functional characterization of several AA transporter 
proteins (Verrey, Singer et al. 2009). In particular, the transport properties were studied with the 
expression of cloned transporters in Xenopus laevis oocytes and with the analysis of uptake and efflux 
rates of radiolabeled substrates. In parallel to the characterization of exogenously expressed AA 
transporters, the localization of several of these proteins in different tissues and at subcellular level has 
been established. Thereby the idea of complex transporter machineries that involves several membrane 
proteins and that work together took place. In this respect, the selective co-expression of selected 
transporters in the heterologous system allowed the identification of functional cooperations, like the 
one proposed for TAT1 and Lat2-4F2hc (Ramadan, Camargo et al. 2007). Finally, much progress in 
the identification of transport proteins has been made by the analysis of the etiology of inherited 
disorders that display specific losses of AAs in the urine (Verrey, Ristic et al. 2005; Broer 2008). 
Among those Hartnup disorder, Cystinuria, Lysinuric protein intolerance and Glycinuria. Many of 
these disorders were attributed to compromised apical transport (Tab. 4), contributing to the fact that 
the basolateral membrane transport remained less characterized.  
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A recent investigation tool is the analysis of specific knock out animal models. Similarly to the study 
of the inherited disorders, the knock out mouse models allow to study the impact of the absence of one 
transporter protein on the whole body. Several animal models of apical transporters have indeed been 
reported: B
0
AT1, B
0
AT3, Tmem27, Ace2, Pept1 and Pept2 (Bohmer, Broer et al. 2005; Daniel, 
Spanier et al. 2006; Danilczyk, Sarao et al. 2006; Camargo, Singer et al. 2009; Singer, Camargo et al. 
2009; Broer, Juelich et al. 2011; Nassl, Rubio-Aliaga et al. 2011). Overall, these animals could at least 
partially compensate for the absence of the transporter and showed in general a mild phenotype similar 
to what we reported for tat1
-/-
: minor reduction in body weight and mild aminoaciduria. This agrees 
with a certain degree of functional overlap, which is probably due to their essential role.  
Only one knock out mouse of the basolateral AA transport machinery has been reported so far: lat2
-/-
 
(slc7a8) (Braun, Wirth et al. 2011). The knock out was generated by the insertion into the second lat2 
exon of a cassette, which causes a premature truncation of the protein. Similarly to apical knock outs, 
this lat2
-/-
 mouse showed a mild phenotype: the mice were undistinguishable in body size and weight, 
but showed several small neutral AAs elevated in serum and lost in urine (Braun, Wirth et al. 2011). 
The parallelism between both suggested for an unchanged fractional excretion. Only a subset of Lat2-
4F2hc substrates was affected and the aromatic AAs were normal. Based on this observation and on a 
slight, non significant, increase in tat1 mRNA level, the authors proposed a compensatory 
involvement of TAT1. The impairment in the AA homeostasis was not further analyzed, since the 
authors aimed at investigating the involvement of Lat2 in thyroid hormone homeostasis.  
 
In this work we analyzed the impact of the absence of two uniporters, TAT1 and Lat4, using the 
respective knock out mouse models. The results presented in chapters 5 and 6 are discussed in the next 
paragraphs (7.1.2 and 7.1.3).  
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7.1.2 tat1 mouse model 
The main results on tat1
-/-
 are discussed in the manuscript in section 5.2. An extended summary: is  
Described in this section: 
 
1. We could show that elevated aromatic AAs in the circulation are caused by the lack of TAT1 
function, which prevents their equilibration between plasma and liver cells. In the wt, the hepatocytes 
work as sink for aromatic AAs and therefore regulate the plasma concentration by clearing the 
aromatic AAs and further metabolizing them (Schimassek and Gerok 1965; Moundras, Remesy et al. 
1993; Brosnan 2003; Gropper 2005). The absence of tat1 prevented this action; therefore, the aromatic 
AAs were accumulated in the plasma. Indeed the cytosolic AA concentration in the hepatocytes was 
normal, whereas in the other major AA pool (i.e. the skeletal muscles) they paralleled the plasma (Fig. 
29A). A similar investigation could potentially reveal the cause of the elevated AAs in the lat2
-/-
 (see 
7.1.2). Uptakes with primary derived hepatocytes of wt and tat1
-/-
 could potentially allow a more 
detailed study of the fluxes between plasma and liver. Interestingly in the past, studies have similarly 
been conducted and transport system identified (e.g. (Fafournoux, Remesy et al. 1983), although 
without being done in specific knock out context. The liver homeostatic function has also been 
discussed in the context of hepatic encephalopathy, where a rise in the so-called Fisher ratio 
(AAA / BCAA) has been reported (James, Ziparo et al. 1979; Dejong, van de Poll et al. 2007). In this 
work we showed that TAT1 is involved in this homeostatic process and that interestingly an alteration 
in the Fisher ratio in our mouse model seems not to lead to the neurological disease, in contrast to 
what has been previously hypothesized (Fischer, Rosen et al. 1976; Dejong, van de Poll et al. 2007). 
Furthermore, we showed that the brain function in tat1
-/-
 mice seems not to be affected. This is not 
completely surprising since tat1 was not shown to be expressed in the blood brain barrier, which 
would prevent an accumulation of TAT1 substrates (Lyck, Ruderisch et al. 2009; Abbott, Patabendige 
et al. 2010). However a complete behavioral screen (e.g. open field, elevated T-maze, hanging 
resistance, etc.) in the search of signs of anxiety and fear has not been perform to definitively rule out 
such phenotype. Furthermore, a quantification of serotonin and catecholamine levels in the brain could 
also be performed.  
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Fig. 29: schematic representation of the impairments observed in tat1
-/-
 mice. A. The absence of TAT1 
caused the uncoupling of liver and plasma aromatic AAs. As a result, tat1
-/- 
show elevated aromatic AAs in 
plasma and skeletal muscle, whereas the liver metabolism regulates its own concentration. One or more 
compensatory transporter(s) with similar properties as TAT1 probably covers TAT1 function in muscles and 
epithelial cells of small intestine and kidney. We propose that this is done to a large extent by Lat4. An 
intracellular accumulation of AA due to defective basolateral export was observed in epithelia. Major losses of 
AAs were found in the urine of tat1
-/- 
under high protein diet. B. Schematic representation of an epithelial cell, 
with intracellular accumulation of AAA due to impaired export caused by TAT1 absence and unpaired Lat2-
4F2hc substrate recycle (red crosses). The accumulation leads to a consequent block of apical import and thus to 
AA losses (red arrow). 
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2. We could show that under normal diet conditions the basolateral transport machinery in kidney 
proximal tubule and small intestine epithelia is not severely impaired by the absence of TAT1. No 
compensatory increase of other AA transporters (mRNAs) was found suggesting that the residual 
aromatic AA transport capacity and the paracellular pathway could compensate TAT1 deficit. Under a 
dietary high protein load a massive presence of aromatic AAs and, in lesser extent, of Lat2-4F2hc 
substrates was found in tat1
-/-
 urine suggesting that the maximal transport rate was exceeded in the 
kidney proximal tubule. We propose that under normal protein diet the concentration is already within 
the so-called splay, where some nephrons have not anymore the capacity of reabsorbing all substrates. 
Under high protein diet the transient absorptive increase of plasma AAs results in their spillover. To 
test this hypothesis the collection of the urine and the plasma could be divided into absorptive and 
postabsorptive phases. This would however require a difficult entrainment of the animals or an 
efficient monitoring. The urinary pattern further suggests the involvement of Lat4, which is also a 
facilitated diffusion pathway, because it transports more efficiently Phe than Tyr and Trp. The 
involvement of a paracellular component as compensatory mechanism remains controversial, 
especially in the intestine. Recently, the absence of the AA transporter B
0
AT1 was reported to 
potentially influence the paracellular permeability, as indirectly studied by the decrease in thight 
junction proteins, Occludin and Claudin-2 (Broer, Juelich et al. 2011). Our data suggest that this 
pathway might be more pronounced in the small intestine, where the net transport measured with 
everted gut sacs did not show a significant difference between wt and tat1
-/-
. However, the mannitol, 
which was especially used to control the paracellular permeability and leakiness, did never parallel the 
steep accumulation of the tested AAs (see 5.3.2 and 5.3.3). Furthermore, a difference between tat1
-/-
 
and wt in mannitol transport has not been observed. The Phe inside of the sac did never exceed the 
concentration in the outside, which suggest for a certain equilibration process in the sac. An enteric 
perfusion and portal vein sampling could be applied to further investigate the gastrointestinal 
functionality of tat1
-/-
.  
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3. We showed with the microSPECT and everted gut sac techniques that the decreased epithelial 
transport may be caused by an intracellular AA accumulation, which leads to a subsequent decrease of 
apical transport (Fig. 29B). The impairment of TAT1 did not only affect the aromatic AA reabsorption 
but also the one of other neutral AAs transported by the exchanger Lat2-4F2hc, as indicated by the 
urinary pattern under high protein diet (see 5.2). In TAT1 absence thus it is most likely that the 
exchanger did not anymore have recycling substrate needed for its proper function. Therefore, these 
data agree with a functional cooperation between TAT1 and Lat2-4F2hc proposed by Ramadan et al. 
(Ramadan, Camargo et al. 2007). In the small intestine a significant accumulation of Phe has been 
observed in the tat1
-/-
 tissue with the everted gut sac assay despite a high variability, which might 
reflect the heterogeneous expression of the transporters along the intestinal tract. MicroSPECT assay 
showed a clear accumulation of 2-I-L-Phe in both kidneys 30 minutes after i.v. injection (see 5.2). 
This tracer was shown previously in X. laevis oocytes expressing TAT1, Lat4 and Lat2-4F2hcto be 
transported as Phe. To test a potential change in liver accumulation of Phe an oral bolus administration 
of tritiated Phe was performed. This did not reveal a difference in liver accumulation between tat1
-/-
 
and wt (data not shown). We hypothesize that the enteric and hepatic metabolism degraded the traced 
AA and prevented a differential accumulation in the liver despite the absence of TAT1. 
 
4. A defect in tat1 has been predicted to be the cause of the blue diaper syndrome (Kim et al., 2001; 
Broer, 2008; Broer and Palacin 2011). This syndrome was initially described by Drummond and co-
workers in 1964 and appears to be extremely rare since only 3 cases have been reported (Drummond et 
al., 2964; Chen et al., 1991; Hoffman, Zschocke and Nyhan). Since an excess of Trp was found in 
stool of the patients, it was proposed that the intestinal bacteria convert the Trp into indoles, which are 
in turn metabolized by the liver into indican and subsequently released into urine or feces. Upon 
oxydation excreted indicans become indigo, causing a peculiar bluish color of the diaper (Broer et al., 
2008). Despite a different bacterial flora, which would not allow to ultimately exclude an involvement 
of tat1 by the absence of bluish pigments in feces or urine in tat1
-/-
, tat1
-/-
 data suggest that this is more  
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unlikely to be. First of all, in contrast to what tat1
-/-
 showed, the children suffered from low circulating 
Trp and did not present specific urinary losses (Drummond et al., 1964). Furthermore, an analysis of 
AA luminal content  in the distal part of the small intestine did not reveal significant differences in Trp 
amounts between tat1
-/-
 and wt littermates (See 5.2), which indicates that the defect on tat1 is not 
sufficient to cause such a dramatic accumulation of Trp. It is possible that the etiology of the disease is 
polygenic involving tat1 and other(s) AA transporters, as reflected in the low incidence of the disease. 
 
5. When subjected to a low protein diet for 8 days both, tat1
-/-
 and wt, showed a drastic decrease of 
urinary AAs (Fig. 16B in paragraph 5.3.1). This phenomenon is thus probably not related with the 
genotype but it opens new perspectives: how is this mechanism happening and why? It is conceivable 
that the kidney proximal tubule reacts upon starvation in order to protect the organism against 
deleterious AA losses. Since the AAs in plasma were maintained within normal levels, it could be that 
the kidney produces more transporter protein in order to reabsorb a larger fraction of AAs.  
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7.1.3 lat4 mouse model 
In light of the results about tat1
-/-
 phenotype, a lat4
-/-
 has been generated with the aim to identify a 
potential compensatory role. The results reported in chapter 6.2.2 about the mixed background lat4
-/- 
survivor family should be taken with caution because the genotype was confirmed by repeated PCRs 
but not yet at protein level. Furthermore, the analysis was limited to very few animals because of the 
unsuccessful attempt to generate other lat4
-/-
. In summary, one lat4
-/-
 female reached adulthood, 
showed first no particular phenotype and gave birth to other three lat4
-/-
, among which two males 
reached adulthood. Those latter failed to generate offsprings and lately a histological analysis showed 
a little number of spermatozoids in their testis. Further analysis was performed at relatively old age. 
One animal showed a left renal hypertrophy and a right renal atrophy with signs of fibrosis. lat4
+/-
 
kidney presented microcyst formations reminiscent of pdk1
+/-
, which has been shown to be involved in 
the development of autosomal dominant polycystic kidney disease (Bastos, Piontek et al. 2009). 
Nevertheless, this observation has not yet been confirmed by more detailed electron microscope 
imaging. Finally, plasma AA values were lying within normal ranges, whereas 24 hour urine presented 
elevated levels of several AAs. This last measurement should also be taken with caution due to the 
above mentioned renal hyper- and atrophy and the late time point of observation. Although one cannot 
exclude that this survivor family had a second mutation that could compensate the deleterious effect of 
the absence of Lat4, the relatively normal phenotype of this mouse remains still controversial. The 
ongoing experiment with the polyclonal antibody, that showed specificity for mLat4, will allow the 
confirmation of the genotype. Furthermore, a series of backcross with an original 129S strain would 
elucidate whether that particular background has a rescuing effect on the lat4
-/-
 phenotype. It is not 
excluded that a difference between 129S and C57BL/6 strains might explain such a protective 
differential impact of lat4 defect. 
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Our preliminary results presented in chapter 6.2.3 about the backcrossed lat4
-/-
 mice clearly indicate 
that the mutation has a lethal impact, at least in the C57BL/6 background. The lat4
-/-
 newborns were 
normal at birth but showed a reduced increment in body weight within the following 48 hours: average 
body weight at 24 hours after birth of 1.1 g for lat4
-/-
 versus 1.6 g for wt and a net weight gain of 0.1 g 
versus 0.4 g between 24 and 48 hours (Fig. 27). Therefore the fetal development seems to be normal 
and the defect in lat4 appears to be prominent from within the first hours of life. All lat4
-/-
 newborns 
presented a so-called milk spot (a white area caused by the milk in the stomach region), which 
suggests that the suckling behavior was not impaired and that the mother did not reject the lat4
-/-
 
offspring. Furthermore, lat4
-/-
 pups were reactive and did not present signs of apathy. The mild 
increase in body weight suggests that the lat4
-/-
 intestine could still absorb a substantial degree of 
nutrients. Further analysis should aim at elucidating the effective lat4
-/-
 intestine transport capacity.  
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7.2 Outlook 
 
 
In this work we identified an important function of tat1 for the maintenance of the aromatic AA 
homeostasis by equilibrating plasma and hepatocytes. This is of particular interest because it attributes 
for the first time a housekeeping function to a high capacity uniporter, which does not allow an 
intracellular accumulation of the substrates. Similar analysis should be performed in other knock out 
mice models that displayed elevated AA in plasma. Furthermore, future studies should aim to 
characterize the AA transport machinery in the metabolic organs like muscles and liver to better 
elucidate the role of AA transporters in the regulation of interorgan AA transport reviewed by Brosnan  
(Brosnan 2003).   
In the light of the minor difference in net epithelial transport displayed by our tat1
-/-
 and by the 
published lat2
-/-
 (Braun, Wirth et al. 2011), the generation of a double knock out mouse and the 
analysis of its urinary pattern might elucidate whether other compensatory mechanism are taking place 
or not. The generation of lat4 combinatorial knock outs is less promising due to the lethality observed 
in lat4
-/-
. However, the analysis of the urinary pattern of lat4
+/-
 in the context of tat1
-/-
 and lat2
-/-
 might 
confirm the compensatory role of lat4.  
The data interpretation of everted gut sacs, microSPECT/CT and tracer administration of in tat1
-/-
 has 
been problematic, probably due to complex metabolic responses and adaptations. A future challenge 
will be the generation of cell lines with reconstituted transport machinery and the isolation of primary 
cells for in vitro flux studies. This would probably allow controlling the environment and therefore to 
generate mathematical flux models that would predict AA dynamics in single organs. Furthermore, 
some additional approaches like microperfusions, micropuncture and microdialysis might allow the 
validation of the model by dynamic probes sampling. 
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Finally, the study of different protein rich diets (see 5.3.1) opened new questions about the regulation 
of transporter proteins: does a specific molecular response to high / low protein load take place in the 
epithelia? Is such a response different in kidney epithelia than in small intestine in order to fulfill 
different functions (e.g. avoid waste versus maximize import)? What is the regulatory pathway and 
how are the AAs sensed? The first approach could be the investigation of up- or down-regulation of 
the different AA transporters within the different protein diet. Furthermore, a regulation at the level of 
membrane trafficking should also be included. For instance a phosphorylation site that might act as 
regulatory element has been found in both, Lat4 and Lat2 (Feric, Zhao et al.). tat1 presents in the        
N-terminus a PEST sequence, which has been correlated to a high turnover degree (Rechsteiner and 
Rogers 1996). More in general, it was demonstrated that Leu plays a role in the control of food intake 
by AMP-activated protein kinase and mTOR pathway (Cota, Proulx et al. 2006; Lynch, Gern et al. 
2006). Nevertheless, the whole mechanism is still not fully understood. Interestingly, a recent 
publication linked impaired feeding behavior with pept1
-/-
 mouse only in the presence of a high protein 
diet (Nassl, Rubio-Aliaga et al. 2011). The effect was linked to a probable decreased Leptin signaling 
in the brain and an Arg cross-talk. In nutritional sciences, it becomes evident that the study of nutrients 
needs to be coupled with the study of the effect that it generates on the transcriptome, proteome and 
metabolome, since all factors are closely interconnected (Rist, Wenzel et al. 2006; Kussmann, Rezzi et 
al. 2008). The study of metabolomics has become possible thanks to advance in technologies like 
liquid chromatography, mass spectrometry and nuclear magnetic resonance spectroscopy. These allow 
the simultaneous analysis of thousand of metabolites. The future challenge will then be to interconnect 
all the different informations into a biological hypothesis and on in silico model by mean of 
informatics (Kussmann, Rezzi et al. 2008). These would also allow finding more subtle metabolic 
compensations in the general homeostasis caused by defective AA transporters with housekeeping 
function.  
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